<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1224" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1224/" /><meta name="ncbi_pagename" content="Mitochondrial Disorders Overview - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Mitochondrial Disorders Overview - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Mitochondrial Disorders Overview" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2014/08/14" /><meta name="citation_author" content="Patrick F Chinnery" /><meta name="citation_pmid" content="20301403" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1224/" /><meta name="citation_keywords" content="Mitochondrial Encephalomyopathies" /><meta name="citation_keywords" content="Mitochondrial Myopathies" /><meta name="citation_keywords" content="Oxidative Phosphorylation Disorders" /><meta name="citation_keywords" content="Respiratory Chain Disorders" /><meta name="citation_keywords" content="Oxidative Phosphorylation Disorders" /><meta name="citation_keywords" content="Respiratory Chain Disorders" /><meta name="citation_keywords" content="Mitochondrial Encephalomyopathies" /><meta name="citation_keywords" content="Mitochondrial Myopathies" /><meta name="citation_keywords" content="Chorea and Dementia" /><meta name="citation_keywords" content="Diabetes and Hearing Loss" /><meta name="citation_keywords" content="Infantile Myopathy and Lactic Acidosis (Fatal and Non-Fatal Forms)" /><meta name="citation_keywords" content="Leber Hereditary Optic Neuropathy" /><meta name="citation_keywords" content="MELAS" /><meta name="citation_keywords" content="MERRF" /><meta name="citation_keywords" content="Mitochondrial DNA Deletion Syndromes" /><meta name="citation_keywords" content="Mitochondrial DNA-Associated Leigh Syndrome and NARP" /><meta name="citation_keywords" content="Mitochondrial Myopathy with Diabetes" /><meta name="citation_keywords" content="Nonsyndromic Hearing Loss and Deafness, Mitochondrial" /><meta name="citation_keywords" content="MERRF/MELAS Overlap Syndrome" /><meta name="citation_keywords" content="ATP synthase subunit a" /><meta name="citation_keywords" content="NADH-ubiquinone oxidoreductase chain 1" /><meta name="citation_keywords" content="NADH-ubiquinone oxidoreductase chain 4" /><meta name="citation_keywords" content="NADH-ubiquinone oxidoreductase chain 5" /><meta name="citation_keywords" content="NADH-ubiquinone oxidoreductase chain 6" /><meta name="citation_keywords" content="MT-ATP6" /><meta name="citation_keywords" content="MT-ND1" /><meta name="citation_keywords" content="MT-ND4" /><meta name="citation_keywords" content="MT-ND5" /><meta name="citation_keywords" content="MT-ND6" /><meta name="citation_keywords" content="MT-TA" /><meta name="citation_keywords" content="MT-TC" /><meta name="citation_keywords" content="MT-TD" /><meta name="citation_keywords" content="MT-TF" /><meta name="citation_keywords" content="MT-TH" /><meta name="citation_keywords" content="MT-TK" /><meta name="citation_keywords" content="MT-TL1" /><meta name="citation_keywords" content="MT-TL2" /><meta name="citation_keywords" content="MT-TM" /><meta name="citation_keywords" content="MT-TQ" /><meta name="citation_keywords" content="MT-TR" /><meta name="citation_keywords" content="MT-TS1" /><meta name="citation_keywords" content="MT-TS2" /><meta name="citation_keywords" content="MT-TT" /><meta name="citation_keywords" content="MT-TV" /><meta name="citation_keywords" content="MT-TW" /><meta name="citation_keywords" content="MT-TY" /><meta name="citation_keywords" content="Mitochondrial Disorders" /><meta name="citation_keywords" content="Overview" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Mitochondrial Disorders Overview" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Patrick F Chinnery" /><meta name="DC.Date" content="2014/08/14" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1224/" /><meta name="description" content="Mitochondrial diseases are a clinically heterogeneous group of disorders that arise as a result of dysfunction of the mitochondrial respiratory chain. They can be caused by mutation of genes encoded by either nuclear DNA or mitochondrial DNA (mtDNA). While some mitochondrial disorders only affect a single organ (e.g., the eye in Leber hereditary optic neuropathy [LHON]), many involve multiple organ systems and often present with prominent neurologic and myopathic features. Mitochondrial disorders may present at any age. Many individuals with a mutation of mtDNA display a cluster of clinical features that fall into a discrete clinical syndrome, such as the Kearns-Sayre syndrome (KSS), chronic progressive external ophthalmoplegia (CPEO), mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS), myoclonic epilepsy with ragged-red fibers (MERRF), neurogenic weakness with ataxia and retinitis pigmentosa (NARP), or Leigh syndrome (LS). However, considerable clinical variability exists and many individuals do not fit neatly into one particular category, which is well-illustrated by the overlapping spectrum of disease phenotypes (including mitochondrial recessive ataxia syndrome (MIRAS) resulting from mutation of the nuclear gene POLG, which has emerged as a major cause of mitochondrial disease. Common clinical features of mitochondrial disease – whether involving a mitochondrial or nuclear gene – include ptosis, external ophthalmoplegia, proximal myopathy and exercise intolerance, cardiomyopathy, sensorineural deafness, optic atrophy, pigmentary retinopathy, and diabetes mellitus. Common central nervous system findings are fluctuating encephalopathy, seizures, dementia, migraine, stroke-like episodes, ataxia, and spasticity. A high incidence of mid- and late pregnancy loss is a common occurrence that often goes unrecognized." /><meta name="og:title" content="Mitochondrial Disorders Overview" /><meta name="og:type" content="book" /><meta name="og:description" content="Mitochondrial diseases are a clinically heterogeneous group of disorders that arise as a result of dysfunction of the mitochondrial respiratory chain. They can be caused by mutation of genes encoded by either nuclear DNA or mitochondrial DNA (mtDNA). While some mitochondrial disorders only affect a single organ (e.g., the eye in Leber hereditary optic neuropathy [LHON]), many involve multiple organ systems and often present with prominent neurologic and myopathic features. Mitochondrial disorders may present at any age. Many individuals with a mutation of mtDNA display a cluster of clinical features that fall into a discrete clinical syndrome, such as the Kearns-Sayre syndrome (KSS), chronic progressive external ophthalmoplegia (CPEO), mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS), myoclonic epilepsy with ragged-red fibers (MERRF), neurogenic weakness with ataxia and retinitis pigmentosa (NARP), or Leigh syndrome (LS). However, considerable clinical variability exists and many individuals do not fit neatly into one particular category, which is well-illustrated by the overlapping spectrum of disease phenotypes (including mitochondrial recessive ataxia syndrome (MIRAS) resulting from mutation of the nuclear gene POLG, which has emerged as a major cause of mitochondrial disease. Common clinical features of mitochondrial disease – whether involving a mitochondrial or nuclear gene – include ptosis, external ophthalmoplegia, proximal myopathy and exercise intolerance, cardiomyopathy, sensorineural deafness, optic atrophy, pigmentary retinopathy, and diabetes mellitus. Common central nervous system findings are fluctuating encephalopathy, seizures, dementia, migraine, stroke-like episodes, ataxia, and spasticity. A high incidence of mid- and late pregnancy loss is a common occurrence that often goes unrecognized." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1224/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/mt-overview/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1224/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8A08C7E03FDDC10000000006AD025F.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1224_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1224_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/mtdna-md-ov/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/mt-mpan/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1224_"><span class="title" itemprop="name">Mitochondrial Disorders Overview</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonyms: Mitochondrial Encephalomyopathies, Mitochondrial Myopathies, Oxidative Phosphorylation Disorders, Respiratory Chain Disorders</div><p class="contrib-group"><span itemprop="author">Patrick F Chinnery</span>, BMedSci, MBBS, PhD, FRCPath, FRCP, FMedSci.</p><a data-jig="ncbitoggler" href="#__NBK1224_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1224_ai__"><div class="contrib half_rhythm"><span itemprop="author">Patrick F Chinnery</span>, BMedSci, MBBS, PhD, FRCPath, FRCP, FMedSci<div class="affiliation small">Department of Clinical Neurosciences<br />University of Cambridge<br />Cambridge, United Kingdom<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ku.ca.mac.lhcsdem@52cfp" class="oemail">ku.ca.mac.lhcsdem@52cfp</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">June 8, 2000</span>; Last Update: <span itemprop="dateModified">August 14, 2014</span>.</p><p><em>Estimated reading time: 25 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="mt-overview.Summary" itemprop="description"><h2 id="_mt-overview_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Mitochondrial diseases are a clinically heterogeneous group of disorders that arise as a result of dysfunction of the mitochondrial respiratory chain. They can be caused by mutation of genes encoded by either nuclear DNA or mitochondrial DNA (mtDNA). While some mitochondrial disorders only affect a single organ (e.g., the eye in Leber hereditary optic neuropathy [LHON]), many involve multiple organ systems and often present with prominent neurologic and myopathic features. Mitochondrial disorders may present at any age. Many individuals with a mutation of mtDNA display a cluster of clinical features that fall into a discrete clinical syndrome, such as the Kearns-Sayre syndrome (KSS), chronic progressive external ophthalmoplegia (CPEO), mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS), myoclonic epilepsy with ragged-red fibers (MERRF), neurogenic weakness with ataxia and retinitis pigmentosa (NARP), or Leigh syndrome (LS). However, considerable clinical variability exists and many individuals do not fit neatly into one particular category, which is well-illustrated by the overlapping spectrum of disease phenotypes (including mitochondrial recessive ataxia syndrome (MIRAS) resulting from mutation of the nuclear <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> <i>POLG</i>, which has emerged as a major cause of mitochondrial disease. Common clinical features of mitochondrial disease &#x02013; whether involving a mitochondrial or nuclear gene &#x02013; include ptosis, external ophthalmoplegia, proximal myopathy and exercise intolerance, cardiomyopathy, sensorineural deafness, optic atrophy, pigmentary retinopathy, and diabetes mellitus. Common central nervous system findings are fluctuating encephalopathy, seizures, dementia, migraine, stroke-like episodes, ataxia, and spasticity. A high incidence of mid- and late pregnancy loss is a common occurrence that often goes unrecognized.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>In some individuals, the clinical picture is characteristic of a specific mitochondrial disorder (e.g., LHON, NARP, or maternally inherited LS), and the diagnosis can be confirmed by identification of a pathogenic mtDNA variant on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> of DNA extracted from a blood sample. In many individuals, such is not the case, and a more structured approach is needed, including family history, blood and/or CSF lactate concentration, neuroimaging, cardiac evaluation, and molecular genetic testing for a mtDNA or nuclear <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. Approaches to molecular genetic testing of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> to consider are serial testing of single genes, <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> testing (simultaneous testing of multiple genes), and/or <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing (e.g., sequencing of the entire mitochondrial genome, <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a>, or <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> to identify a pathogenic variant in a nuclear gene). In many individuals in whom molecular genetic testing does not yield or confirm a diagnosis, further investigation of suspected mitochondrial disease can involve a range of different clinical tests, including muscle biopsy for respiratory chain function.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>Mitochondrial disorders may be caused by defects of nuclear DNA or mtDNA. Nuclear <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> defects may be inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> or <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. Mitochondrial DNA defects are transmitted by maternal inheritance. Mitochondrial DNA deletions generally occur <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> and thus cause disease in one family member only, with an approximate <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> of 1 in 24. Mitochondrial DNA single-nucleotide variants and duplications may be transmitted down the maternal line. The father of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is not at risk of having the mtDNA <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, but the mother of a proband (usually) has the mitochondrial pathogenic variant and may or may not have symptoms. A male does not transmit the mtDNA pathogenic variant to his offspring. A female harboring a <a class="def" href="/books/n/gene/glossary/def-item/heteroplasmic/">heteroplasmic</a> mtDNA <a class="def" href="/books/n/gene/glossary/def-item/single-nucleotide-variant/">single-nucleotide variant</a> may transmit a variable amount of mutated mtDNA to her offspring, resulting in considerable clinical variability among sibs within the same family. Prenatal genetic testing and interpretation of test results for mtDNA disorders are difficult because of mtDNA <a class="def" href="/books/n/gene/glossary/def-item/heteroplasmy/">heteroplasmy</a>. <i>De novo</i> tissue-specific pathogenic nucleotide variants are rare, but associated with low recurrence risks.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> The management of mitochondrial disease is largely supportive and may include early diagnosis and treatment of diabetes mellitus, cardiac pacing, ptosis correction, intraocular lens replacement for cataracts, and cochlear implantation for sensorineural hearing loss. Individuals with complex I and/or complex II deficiency may benefit from oral administration of riboflavin; those with ubiquinone (coenzyme Q<sub>10</sub>) deficiency may benefit from oral coenzyme Q<sub>10</sub> therapy; and those with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) may benefit from hematopoietic stem cell transplantation.</p></div></div><div id="mt-overview.Definition"><h2 id="_mt-overview_Definition_">Definition</h2><p>Mitochondrial diseases are a clinically heterogeneous group of disorders that arise as a result of dysfunction of the mitochondrial respiratory chain. The mitochondrial respiratory chain is the essential final common pathway for aerobic metabolism, and tissues and organs that are highly dependent on aerobic metabolism are preferentially involved in mitochondrial disorders [<a class="bk_pop" href="#mt-overview.REF.wallace.1999.1482">Wallace 1999</a>].</p><p>More than 70 different polypeptides interact on the inner mitochondrial membrane to form the respiratory chain. The vast majority of subunits are synthesized within the cytosol from nuclear <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> transcripts, but 13 essential subunits are encoded by the 16.5-kb mitochondrial DNA (mtDNA) [<a class="bk_pop" href="#mt-overview.REF.larsson.1995.151">Larsson &#x00026; Clayton 1995</a>].</p><p><a class="figpopup" href="/books/NBK1224/figure/mt-overview.F1/?report=objectonly" target="object" rid-figpopup="figmtoverviewF1" rid-ob="figobmtoverviewF1">Figure 1</a> illustrates the structure of the human mitochondrial genome.</p><div class="iconblock whole_rhythm clearfix ten_col fig" id="figmtoverviewF1" co-legend-rid="figlgndmtoverviewF1"><a href="/books/NBK1224/figure/mt-overview.F1/?report=objectonly" target="object" title="Figure 1. " class="img_link icnblk_img figpopup" rid-figpopup="figmtoverviewF1" rid-ob="figobmtoverviewF1"><img class="small-thumb" src="/books/NBK1224/bin/mt-overview-Image001.gif" src-large="/books/NBK1224/bin/mt-overview-Image001.jpg" alt="Figure 1. " /></a><div class="icnblk_cntnt" id="figlgndmtoverviewF1"><h4 id="mt-overview.F1"><a href="/books/NBK1224/figure/mt-overview.F1/?report=objectonly" target="object" rid-ob="figobmtoverviewF1">Figure 1. </a></h4><p class="float-caption no_bottom_margin">The human mitochondrial genome </p></div></div><ul><li class="half_rhythm"><div>The 1.1-kb D-loop (noncoding region) is involved in the regulation of transcription and replication of the molecule, and is the only region not directly involved in the synthesis of respiratory chain polypeptides.</div></li><li class="half_rhythm"><div><i>MT-ND1</i> through <i>MT-ND6</i> and <i>MT-ND4L</i> encode seven subunits of complex I.</div></li><li class="half_rhythm"><div>Cyt b is the only mtDNA-encoded complex III subunit.</div></li><li class="half_rhythm"><div><i>MT-CO1</i> to <i>MT-CO3</i> encode for three of the complex IV (cytochrome c oxidase, or COX) subunits.</div></li><li class="half_rhythm"><div><i>MT-ATP6</i> and <i>MT-ATP8</i> encode for two subunits of complex V: ATPase6 and ATPase8, respectively.</div></li><li class="half_rhythm"><div>Two ribosomal RNA genes (<i>MT-RNR1</i> and <i>MT-RNR2</i>, encoding 12S and 16S rRNA) and 22 transfer RNA genes are interspaced between the protein-encoding genes. These provide the necessary RNA components for intra-mitochondrial protein synthesis.</div></li><li class="half_rhythm"><div>O<sub>H</sub> and O<sub>L</sub> are the origins of heavy- and light-strand mtDNA replication.</div></li></ul><p>Each human cell contains thousands of copies of mtDNA. At birth these are usually all identical (<a class="def" href="/books/n/gene/glossary/def-item/homoplasmy/">homoplasmy</a>). By contrast, individuals with mitochondrial disorders resulting from mutation of mtDNA may harbor a mixture of mutated and wild type mtDNA within each cell (<a class="def" href="/books/n/gene/glossary/def-item/heteroplasmy/">heteroplasmy</a>) [<a class="bk_pop" href="#mt-overview.REF.holt.1988.717">Holt et al 1988</a>, <a class="bk_pop" href="#mt-overview.REF.holt.1990.428">Holt et al 1990</a>]. Single-cell studies and cybrid-cell studies have shown that the proportion of mutated mtDNA must exceed a critical threshold level before a cell expresses a biochemical abnormality of the mitochondrial respiratory chain (the threshold effect) [<a class="bk_pop" href="#mt-overview.REF.schon.1997.131">Schon et al 1997</a>]. The percentage level of mutated mtDNA may vary among individuals within the same family, and also among organs and tissues within the same individual [<a class="bk_pop" href="#mt-overview.REF.macmillan.1993.1586">Macmillan et al 1993</a>]. This is one explanation for the varied clinical <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> seen in individuals with disorders caused by mutation of mtDNA. For example, in individuals harboring the <a class="figpopup" href="/books/NBK1224/table/mt-overview.T.genetic_classification_of_1/?report=objectonly" target="object" rid-figpopup="figmtoverviewTgeneticclassificationof1" rid-ob="figobmtoverviewTgeneticclassificationof1">m.8993T&#x0003e;G</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, higher percentage levels of mutated mtDNA are seen in those presenting with Leigh syndrome than in those presenting with neurogenic weakness with ataxia and retinitis pigmentosa (NARP) [<a class="bk_pop" href="#mt-overview.REF.uziel.1997.16">Uziel et al 1997</a>, <a class="bk_pop" href="#mt-overview.REF.white.1999a.474">White et al 1999a</a>].</p><p>Other important mitochondrial mechanisms controlled by nuclear genes include:</p><ul><li class="half_rhythm"><div>Disorders of mtDNA maintenance (mtDNA depletion or secondary pathogenic mtDNA variants);</div></li><li class="half_rhythm"><div>Disorders of mitochondrial protein synthesis;</div></li><li class="half_rhythm"><div>Disorders of coenzyme Q<sub>10</sub> biosynthesis;</div></li><li class="half_rhythm"><div>Disorders of the respiratory chain complexes or their assembly.</div></li></ul><p>With more than 1000 nuclear genes encoding mitochondrial proteins, the molecular diagnosis can be challenging.</p><p><b>Secondary mitochondrial dysfunction in human diseases.</b> Mitochondrial dysfunction is also seen in a number of different genetic disorders, including <a href="/books/n/gene/ee/">ethylmalonic aciduria</a> (caused by mutation of <i>ETHE1</i>) [<a class="bk_pop" href="#mt-overview.REF.tiranti.2009.200">Tiranti et al 2009</a>], <a href="/books/n/gene/friedreich/">Friedreich ataxia</a> (<i>FXN</i>) [<a class="bk_pop" href="#mt-overview.REF.r_tig.1997.215">R&#x000f6;tig et al 1997</a>], <a href="/books/n/gene/spg7/">hereditary spastic paraplegia 7</a> (<i>SPG7</i>) [<a class="bk_pop" href="#mt-overview.REF.casari.1998.973">Casari et al 1998</a>], and <a href="/books/n/gene/wilson/">Wilson disease</a> (<i>ATP7B</i>) [<a class="bk_pop" href="#mt-overview.REF.lutsenko.1998.6004">Lutsenko &#x00026; Cooper 1998</a>], and is also seen as part of the aging process. These are not strictly mitochondrial diseases. The term mitochondrial disorder usually refers to primary disorders of mitochondrial metabolism affecting oxidative phosphorylation.</p><div id="mt-overview.Clinical_Manifestations"><h3>Clinical Manifestations</h3><p>Some mitochondrial disorders affect a single organ (e.g., the eye in <a href="/books/n/gene/lhon/">Leber hereditary optic neuropathy</a> and the ear in nonsyndromic hearing loss with or without aminoglycoside sensitivity; see <a href="/books/n/gene/mt-deafness/">Mitochondrial Hearing Loss and Deafness</a>), but many involve multiple organ systems and often present with prominent neurologic and myopathic features.</p><p>Mitochondrial disorders may present at any age [<a class="bk_pop" href="#mt-overview.REF.leonard.2000a.299">Leonard &#x00026; Schapira 2000a</a>, <a class="bk_pop" href="#mt-overview.REF.leonard.2000b.389">Leonard &#x00026; Schapira 2000b</a>]. Until recently it was generally thought that nuclear DNA abnormalities present in childhood and mtDNA abnormalities (primary or secondary to a nuclear DNA abnormality) present in late childhood or adult life; however, recent advances have shown that many mtDNA disorders present in childhood, and many nuclear genetic mitochondrial disorders present in adult life.</p><p>Many individuals display a cluster of clinical features that fall into a discrete clinical syndrome (<a class="figpopup" href="/books/NBK1224/table/mt-overview.T.clinical_syndromes_of_mito/?report=objectonly" target="object" rid-figpopup="figmtoverviewTclinicalsyndromesofmito" rid-ob="figobmtoverviewTclinicalsyndromesofmito">Table 1</a>) [<a class="bk_pop" href="#mt-overview.REF.dimauro.2001.18">DiMauro &#x00026; Schon 2001</a>, <a class="bk_pop" href="#mt-overview.REF.munnich.2001.4">Munnich &#x00026; Rustin 2001</a>], such as <a href="/books/n/gene/kss/">Kearns-Sayre syndrome</a> (KSS), <a href="/books/n/gene/kss/">chronic progressive external ophthalmoplegia</a> (CPEO) [<a class="bk_pop" href="#mt-overview.REF.moraes.1989.1293">Moraes et al 1989</a>], mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (<a href="/books/n/gene/melas/">MELAS</a>) [<a class="bk_pop" href="#mt-overview.REF.hirano.1992.125">Hirano et al 1992</a>], myoclonic epilepsy with ragged-red fibers (<a href="/books/n/gene/merrf/">MERRF</a>) [<a class="bk_pop" href="#mt-overview.REF.hammans.1993.617">Hammans et al 1993</a>], neurogenic weakness with ataxia and retinitis pigmentosa (<a href="/books/n/gene/narp/">NARP</a>) [<a class="bk_pop" href="#mt-overview.REF.holt.1990.428">Holt et al 1990</a>], or <a href="/books/n/gene/narp/">Leigh syndrome</a> (LS) [<a class="bk_pop" href="#mt-overview.REF.ciafaloni.1993.419">Ciafaloni et al 1993</a>]. However, there is often considerable clinical variability and many <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals do not fit neatly into one particular category. Mutation of <i>POLG</i>, which has emerged as a major cause of mitochondrial disease, illustrates this well, with an overlapping spectrum of disease phenotypes resulting from pathogenic variants in the same <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> (see <a href="/books/n/gene/alpers/"><i>POLG</i>-Related Disorders</a>).</p><p>Common clinical features of mitochondrial disease include ptosis, external ophthalmoplegia, proximal myopathy and exercise intolerance, cardiomyopathy, sensorineural deafness, optic atrophy, pigmentary retinopathy, and diabetes mellitus. Diabetes mellitus and deafness is also a well-recognized clinical <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> [<a class="bk_pop" href="#mt-overview.REF.van_den_ouweland.1992.368">van den Ouweland et al 1992</a>].</p><p>The central nervous system findings are often fluctuating encephalopathy, seizures, dementia, migraine, stroke-like episodes, ataxia, and spasticity. Chorea and dementia may also be prominent features [<a class="bk_pop" href="#mt-overview.REF.nelson.1995.400">Nelson et al 1995</a>].</p><p>A high incidence of mid- and late pregnancy loss is also a common feature that often remains unrecognized [<a class="bk_pop" href="#mt-overview.REF.tay.2004.950">Tay et al 2004</a>].</p><div id="mt-overview.T.clinical_syndromes_of_mito" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Clinical Syndromes of Mitochondrial Diseases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1224/table/mt-overview.T.clinical_syndromes_of_mito/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__mt-overview.T.clinical_syndromes_of_mito_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Disorder</th><th id="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Primary Features</th><th id="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Additional Features</th></tr></thead><tbody><tr><td headers="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/alpers/">Alpers-Huttenlocher syndrome</a></td><td headers="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Hypotonia</div></li><li class="half_rhythm"><div>Seizures</div></li><li class="half_rhythm"><div>Liver failure</div></li></ul>
</td><td headers="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Renal tubulopathy</td></tr><tr><td headers="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/alpers/">Ataxia neuropathy syndromes</a> (ANS): Including MIRAS, SCAE, SANDO, MEMSA</td><td headers="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>SANDO</div></li><li class="half_rhythm"><div>Other ANS: Sensory axonal neuropathy w/variable sensory &#x00026; cerebellar ataxia</div></li></ul>
</td><td headers="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Epilepsy, dysarthria, &#x00026;/or myopathy</td></tr><tr><td headers="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/kss/">CPEO</a></td><td headers="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>External ophthalmoplegia</div></li><li class="half_rhythm"><div>Bilateral ptosis</div></li></ul>
</td><td headers="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mild proximal myopathy</td></tr><tr><td headers="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/kss/">KSS</a></td><td headers="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>PEO onset at age &#x0003c;20 yrs</div></li><li class="half_rhythm"><div>Pigmentary retinopathy</div></li><li class="half_rhythm"><div>One of the following: CSF protein &#x0003e;1g/L, cerebellar ataxia, heart block</div></li></ul>
</td><td headers="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Bilateral deafness</div></li><li class="half_rhythm"><div>Myopathy</div></li><li class="half_rhythm"><div>Dysphagia</div></li><li class="half_rhythm"><div>Diabetes mellitus</div></li><li class="half_rhythm"><div>Hypoparathyroidism</div></li><li class="half_rhythm"><div>Dementia</div></li></ul>
</td></tr><tr><td headers="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/kss/">Pearson syndrome</a></td><td headers="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Sideroblastic anemia of childhood</div></li><li class="half_rhythm"><div>Pancytopenia</div></li><li class="half_rhythm"><div>Exocrine pancreatic failure</div></li></ul>
</td><td headers="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Renal tubular defects</td></tr><tr><td headers="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Infantile myopathy and lactic acidosis (fatal &#x00026; non-fatal forms)</td><td headers="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Hypotonia in 1st yr of life</div></li><li class="half_rhythm"><div>Feeding &#x00026; respiratory difficulties</div></li></ul>
</td><td headers="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Fatal form may be associated w/cardiomyopathy &#x00026;/or Toni-Fanconi-Debre syndrome.</td></tr><tr><td headers="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/narp/">Leigh syndrome</a></td><td headers="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Subacute relapsing encephalopathy</div></li><li class="half_rhythm"><div>Cerebellar and brain stem signs</div></li><li class="half_rhythm"><div>Infantile onset</div></li></ul>
</td><td headers="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Basal ganglia lucencies</div></li><li class="half_rhythm"><div>Maternal history of neurologic disease or Leigh syndrome</div></li></ul>
</td></tr><tr><td headers="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/narp/">NARP</a></td><td headers="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Late-childhood or adult-onset peripheral neuropathy</div></li><li class="half_rhythm"><div>Ataxia</div></li><li class="half_rhythm"><div>Pigmentary retinopathy</div></li></ul>
</td><td headers="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Basal ganglia lucencies</div></li><li class="half_rhythm"><div>Abnormal electroretinogram</div></li><li class="half_rhythm"><div>Sensorimotor neuropathy</div></li></ul>
</td></tr><tr><td headers="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/melas/">MELAS</a></td><td headers="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Stroke-like episodes at age &#x0003c;40 years</div></li><li class="half_rhythm"><div>Seizures &#x00026;/or dementia</div></li><li class="half_rhythm"><div>Ragged-red fibers &#x00026;/or lactic acidosis</div></li></ul>
</td><td headers="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Diabetes mellitus</div></li><li class="half_rhythm"><div>Cardiomyopathy (initially hypertrophic; later dilated)</div></li><li class="half_rhythm"><div>Bilateral deafness</div></li><li class="half_rhythm"><div>Pigmentary retinopathy</div></li><li class="half_rhythm"><div>Cerebellar ataxia</div></li></ul>
</td></tr><tr><td headers="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/alpers/">MEMSA</a>&#x000a0;<sup>1</sup></td><td headers="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Myopathy</div></li><li class="half_rhythm"><div>Seizures</div></li><li class="half_rhythm"><div>Cerebellar ataxia</div></li></ul>
</td><td headers="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Dementia</div></li><li class="half_rhythm"><div>Peripheral neuropathy</div></li><li class="half_rhythm"><div>Spasticity</div></li></ul>
</td></tr><tr><td headers="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/merrf/">MERRF</a></td><td headers="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Myoclonus</div></li><li class="half_rhythm"><div>Seizures</div></li><li class="half_rhythm"><div>Cerebellar ataxia</div></li><li class="half_rhythm"><div>Myopathy</div></li></ul>
</td><td headers="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Dementia</div></li><li class="half_rhythm"><div>Optic atrophy</div></li><li class="half_rhythm"><div>Bilateral deafness</div></li><li class="half_rhythm"><div>Peripheral neuropathy</div></li><li class="half_rhythm"><div>Spasticity</div></li><li class="half_rhythm"><div>Multiple lipomata</div></li></ul>
</td></tr><tr><td headers="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/lhon/">LHON</a></td><td headers="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Subacute painless bilateral visual failure</div></li><li class="half_rhythm"><div>Males:females ~4:1</div></li><li class="half_rhythm"><div>Median age of onset 24 years</div></li></ul>
</td><td headers="hd_h_mt-overview.T.clinical_syndromes_of_mito_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Dystonia</div></li><li class="half_rhythm"><div>Cardiac pre-excitation syndromes</div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">CPEO = chronic progressive external ophthalmoplegia; KSS = Kearns-Sayre syndrome; LHON = Leber hereditary optic neuropathy; MELAS = mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes; MEMSA = myoclonic epilepsy myopathy sensory ataxia; MERRF = myoclonic epilepsy with ragged-red fibers; MIRAS = mitochondrial recessive ataxia syndrome; NARP = neurogenic weakness with ataxia and retinitis pigmentosa; SANDO = sensory ataxia neuropathy, dysarthria, ophthalmoplegia; SCAE = spinocerebellar ataxia with epilepsy</p></div></dd><dt>1. </dt><dd><div id="mt-overview.TF.1.1"><p class="no_margin">Also referred to as MIRAS and SCAE</p></div></dd></dl></div></div></div></div><div id="mt-overview.Differential_Diagnosis"><h3>Differential Diagnosis</h3><p><b>Lactic acidosis.</b> It is important to exclude other causes of lactic acidosis when interpreting these values. For example, the concentration of lactate may be elevated in the plasma and CSF of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals following a seizure. CSF lactate concentration may be elevated following an ischemic stroke.</p><p><b>White matter abnormalities.</b> See <a class="bk_pop" href="#mt-overview.REF.scarpelli.2013.520">Scarpelli et al [2013]</a>, <a class="bk_pop" href="#mt-overview.REF.morat_.2014.1878">Morat&#x000f3; et al [2014]</a>, and <a class="bk_pop" href="#mt-overview.REF.wu.2016.1034">Wu et al [2016]</a>.</p></div><div id="mt-overview.Prevalence"><h3>Prevalence</h3><p>Mitochondrial disorders are more common than was previously thought (<a class="figpopup" href="/books/NBK1224/table/mt-overview.T.epidemiology_of_mitochondr/?report=objectonly" target="object" rid-figpopup="figmtoverviewTepidemiologyofmitochondr" rid-ob="figobmtoverviewTepidemiologyofmitochondr">Table 2</a>). Based on the available data, a conservative estimate for the prevalence of all mitochondrial diseases is 11.5:100,000 (~1:8500). <a class="bk_pop" href="#mt-overview.REF.arpa.2003.690">Arpa et al [2003]</a> calculated prevalence in Spain at 5.7:100,000 for individuals older than age 14 years.</p><div id="mt-overview.T.epidemiology_of_mitochondr" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Epidemiology of Mitochondrial Disease</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1224/table/mt-overview.T.epidemiology_of_mitochondr/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__mt-overview.T.epidemiology_of_mitochondr_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_mt-overview.T.epidemiology_of_mitochondr_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Study Population</th><th id="hd_h_mt-overview.T.epidemiology_of_mitochondr_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Pathogenic Variant or Disease</th><th id="hd_h_mt-overview.T.epidemiology_of_mitochondr_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Disease Prevalence / 100,000<br />(95% C.I.)&#x000a0;<sup>1</sup></th></tr></thead><tbody><tr><td headers="hd_h_mt-overview.T.epidemiology_of_mitochondr_1_1_1_1" rowspan="6" scope="row" colspan="1" style="text-align:left;vertical-align:middle;">Northern England&#x000a0;<sup>2</sup>
<ul><li class="half_rhythm"><div>Point prevalence August 1997</div></li><li class="half_rhythm"><div>Population size: 2,122,290</div></li></ul>
</td><td headers="hd_h_mt-overview.T.epidemiology_of_mitochondr_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">All mtDNA deletions</td><td headers="hd_h_mt-overview.T.epidemiology_of_mitochondr_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1.33&#x000a0;<sup>3</sup><br />(0.76-1.89)</td></tr><tr><td headers="hd_h_mt-overview.T.epidemiology_of_mitochondr_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">All mtDNA single nucleotide variants</td><td headers="hd_h_mt-overview.T.epidemiology_of_mitochondr_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">5.24&#x000a0;<sup>3</sup><br />(4.12-6.37)</td></tr><tr><td headers="hd_h_mt-overview.T.epidemiology_of_mitochondr_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">m.11778G&#x0003e;A, m.3460G&#x0003e;A (LHON)</td><td headers="hd_h_mt-overview.T.epidemiology_of_mitochondr_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3.29&#x000a0;<sup>3</sup><br />(2.39-4.18)</td></tr><tr><td headers="hd_h_mt-overview.T.epidemiology_of_mitochondr_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">m.3243A&#x0003e;G</td><td headers="hd_h_mt-overview.T.epidemiology_of_mitochondr_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0.95&#x000a0;<sup>3</sup><br />(0.47-1.43)</td></tr><tr><td headers="hd_h_mt-overview.T.epidemiology_of_mitochondr_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">m.8344A&#x0003e;G</td><td headers="hd_h_mt-overview.T.epidemiology_of_mitochondr_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0.25&#x000a0;<sup>3</sup><br />(0.01-0.5)</td></tr><tr><td headers="hd_h_mt-overview.T.epidemiology_of_mitochondr_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">All pathogenic mtDNA variants</td><td headers="hd_h_mt-overview.T.epidemiology_of_mitochondr_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">6.57&#x000a0;<sup>4</sup><br />(5.30-7.83)</td></tr><tr><td headers="hd_h_mt-overview.T.epidemiology_of_mitochondr_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Northern Finland&#x000a0;<sup>5</sup>
<ul><li class="half_rhythm"><div>Adult point prevalence</div></li><li class="half_rhythm"><div>Population size: 245,201</div></li></ul>
</td><td headers="hd_h_mt-overview.T.epidemiology_of_mitochondr_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">m.3243A&#x0003e;G</td><td headers="hd_h_mt-overview.T.epidemiology_of_mitochondr_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">5.71<br />(4.53-6.89)</td></tr><tr><td headers="hd_h_mt-overview.T.epidemiology_of_mitochondr_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Western Sweden&#x000a0;<sup>6</sup>
<ul><li class="half_rhythm"><div>Children age &#x0003c;16: 385,616</div></li></ul>
</td><td headers="hd_h_mt-overview.T.epidemiology_of_mitochondr_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Childhood mitochondrial encephalomyopathies</td><td headers="hd_h_mt-overview.T.epidemiology_of_mitochondr_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4.7&#x000a0;<sup>7</sup><br />(2.8-7.6)</td></tr><tr><td headers="hd_h_mt-overview.T.epidemiology_of_mitochondr_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Victoria, Australia&#x000a0;<sup>8</sup>
<ul><li class="half_rhythm"><div>Birth prevalence: 1,710,000 births</div></li></ul>
</td><td headers="hd_h_mt-overview.T.epidemiology_of_mitochondr_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Childhood respiratory chain disease</td><td headers="hd_h_mt-overview.T.epidemiology_of_mitochondr_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4.7&#x000a0;<sup>9</sup><br />(3.2-5.0)</td></tr><tr><td headers="hd_h_mt-overview.T.epidemiology_of_mitochondr_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Summary</td><td headers="hd_h_mt-overview.T.epidemiology_of_mitochondr_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mitochondrial disease (adults and children)</td><td headers="hd_h_mt-overview.T.epidemiology_of_mitochondr_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~11.5</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note: The mitochondrial genetic code varies from the <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> genetic code given in the <a href="/books/n/gene/app3/">Quick Reference</a>. For the genetic code, <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> structure, and other features of the mitochondrial genome see <a href="http://www.mitomap.org/MITOMAP" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MITOMAP: A Human Mitochondrial Genome Database</a>. Variants are named according to current nomenclature guidelines (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). The reference sequence for the human mitochondrial DNA is <a href="/nuccore/NC_012920.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NC_012920<wbr style="display:inline-block"></wbr>​.1</a> (<a href="http://www.mitomap.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www<wbr style="display:inline-block"></wbr>​.mitomap.org</a>).</p></div></dd><dt>1. </dt><dd><div id="mt-overview.TF.2.1"><p class="no_margin">C.I. = confidence interval</p></div></dd><dt>2. </dt><dd><div id="mt-overview.TF.2.2"><p class="no_margin"><a class="bk_pop" href="#mt-overview.REF.chinnery.2000.188">Chinnery et al [2000]</a></p></div></dd><dt>3. </dt><dd><div id="mt-overview.TF.2.3"><p class="no_margin">The prevalence of mtDNA disease is based on <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> adults (age 16-65 yrs for males; 16-60 yrs for females).</p></div></dd><dt>4. </dt><dd><div id="mt-overview.TF.2.4"><p class="no_margin">The prevalence of mtDNA pathogenic variants is based on all individuals under retirement age (&#x0003c;65 yrs for males; &#x0003c;60 yrs for females).</p></div></dd><dt>5. </dt><dd><div id="mt-overview.TF.2.5"><p class="no_margin"><a class="bk_pop" href="#mt-overview.REF.majamaa.1998.447">Majamaa et al [1998]</a></p></div></dd><dt>6. </dt><dd><div id="mt-overview.TF.2.6"><p class="no_margin"><a class="bk_pop" href="#mt-overview.REF.darin.2001.377">Darin et al [2001]</a></p></div></dd><dt>7. </dt><dd><div id="mt-overview.TF.2.7"><p class="no_margin">Point prevalence 1 January 1999</p></div></dd><dt>8. </dt><dd><div id="mt-overview.TF.2.8"><p class="no_margin"><a class="bk_pop" href="#mt-overview.REF.skladal.2003.1905">Skladal et al [2003]</a></p></div></dd><dt>9. </dt><dd><div id="mt-overview.TF.2.9"><p class="no_margin">Birth prevalence measured between 1987 and 1996</p></div></dd></dl></div></div></div></div></div><div id="mt-overview.Causes"><h2 id="_mt-overview_Causes_">Causes</h2><p>Mitochondrial disorders can be caused by mutation of nuclear DNA or mitochondrial DNA [<a class="bk_pop" href="#mt-overview.REF.koopman.2012.1132">Koopman et al 2012</a>].</p><p>The classification of mitochondrial disease is difficult. Although a purely clinical classification can be helpful (<a class="figpopup" href="/books/NBK1224/table/mt-overview.T.clinical_syndromes_of_mito/?report=objectonly" target="object" rid-figpopup="figmtoverviewTclinicalsyndromesofmito" rid-ob="figobmtoverviewTclinicalsyndromesofmito">Table 1</a>), many individuals do not fall into one specific disease category. The situation is made all the more complex by the poor correlation between <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a> and <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. For example, among a group of clinically indistinguishable individuals with external ophthalmoplegia, some may have a large <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of mtDNA, others a single nucleotide variant of mtDNA (e.g., m.3243A&#x0003e;G), and still others a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in a nuclear <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> causing secondary mtDNA abnormalities (e.g., <i>ANT1</i> pathogenic variants).</p><p>Recent advances in our understanding of the molecular genetic basis of mitochondrial disease have helped in the classification of these disorders by nuclear DNA mutation (<a class="figpopup" href="/books/NBK1224/table/mt-overview.T.genetic_classification_of/?report=objectonly" target="object" rid-figpopup="figmtoverviewTgeneticclassificationof" rid-ob="figobmtoverviewTgeneticclassificationof">Table 3a</a>) and mitochondrial DNA mutation (<a class="figpopup" href="/books/NBK1224/table/mt-overview.T.genetic_classification_of_1/?report=objectonly" target="object" rid-figpopup="figmtoverviewTgeneticclassificationof1" rid-ob="figobmtoverviewTgeneticclassificationof1">Table 3b</a>). Nonetheless, the genetic approach to classification also has certain drawbacks:</p><ul><li class="half_rhythm"><div>It is currently not possible to identify the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in a significant number of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals, particularly children [<a class="bk_pop" href="#mt-overview.REF.lieber.2013.1762">Lieber et al 2013</a>]</div></li><li class="half_rhythm"><div>The same <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> may cause a range of very different clinical syndromes (e.g., the m.3243A&#x0003e;G single nucleotide variant may cause CPEO, diabetes mellitus and deafness, or a severe encephalopathy with recurrent strokes and epilepsy).</div></li><li class="half_rhythm"><div>The rate of new <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> discovery using <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing methods (e.g., <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a>) makes it difficult for any one resource to maintain a comprehensive list of all genes known to impair mitochondrial function.</div></li></ul><div id="mt-overview.T.genetic_classification_of" class="table"><h3><span class="label">Table 3a. </span></h3><div class="caption"><p>Genetic Classification of Human Mitochondrial Disorders: Mutation of Nuclear DNA</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1224/table/mt-overview.T.genetic_classification_of/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__mt-overview.T.genetic_classification_of_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_mt-overview.T.genetic_classification_of_1_1_1_1" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Disorders</th><th id="hd_h_mt-overview.T.genetic_classification_of_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mutation of Nuclear DNA</th></tr></thead><tbody><tr><td headers="hd_h_mt-overview.T.genetic_classification_of_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Nuclear</b><br /><b>genetic disorders</b><br /><b>of the mt</b><br /><b>respiratory</b><br /><b>chain</b></td><td headers="hd_h_mt-overview.T.genetic_classification_of_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Mutated genes encoding structural subunits&#x000a0;<sup>1</sup></b></td><td headers="hd_h_mt-overview.T.genetic_classification_of_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Leigh syndrome w/complex I deficiency (<i>NDUFS1, NDUFS4, NDUFS7, NDUFS8, NDUFV1</i>)</div></li><li class="half_rhythm"><div>Leigh syndrome w/complex II deficiency (<i>SDHA</i>)</div></li><li class="half_rhythm"><div>Leukodystrophy w/complex II deficiency (<i>SDHAF1</i>)</div></li><li class="half_rhythm"><div>Cardiomyopathy &#x00026; encephalopathy (complex I deficiency) (<i>NDUFS2</i>)</div></li><li class="half_rhythm"><div>Optic atrophy &#x00026; ataxia (complex II deficiency) (<i>SDHA</i>)</div></li><li class="half_rhythm"><div>Hypokalemia &#x00026; lactic acidosis (complex III deficiency) (<i>UQCRB</i>)</div></li></ul>
</td></tr><tr><td headers="hd_h_mt-overview.T.genetic_classification_of_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Mutated genes encoding assembly factors&#x000a0;<sup>1</sup></b></td><td headers="hd_h_mt-overview.T.genetic_classification_of_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Leigh syndrome (<i>SURF1</i>, <i>LRPPRC</i>)</div></li><li class="half_rhythm"><div>Hepatopathy &#x00026; ketoacidosis (<i>SCO1</i>)</div></li><li class="half_rhythm"><div>Cardiomyopathy &#x00026; encephalopathy (<i>SCO2</i>)</div></li><li class="half_rhythm"><div>Leukodystrophy &#x00026; renal tubulopathy (<i>COX10</i>)</div></li><li class="half_rhythm"><div>Hypertrophic cardiomyopathy (<i>COX15</i>)</div></li><li class="half_rhythm"><div>Encephalopathy, liver failure, renal tubulopathy (w/complex III deficiency) (<i>BCS1L</i>)</div></li><li class="half_rhythm"><div>Encephalopathy (w/complex V deficiency) (<i>ATPAF2</i>)</div></li></ul>
</td></tr><tr><td headers="hd_h_mt-overview.T.genetic_classification_of_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Mutated genes encoding translation factors&#x000a0;<sup>1</sup></b></td><td headers="hd_h_mt-overview.T.genetic_classification_of_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Leigh syndrome, liver failure, &#x00026; lactic acidosis (<i>GFM1</i>)</div></li><li class="half_rhythm"><div>Lactic acidosis, developmental failure, &#x00026; dysmorphism (<i>MRPS16</i>)</div></li><li class="half_rhythm"><div>Myopathy &#x00026; sideroblastic anemia (<i>PUS1</i>)</div></li><li class="half_rhythm"><div>Leukodystrophy &#x00026; polymicrogyria (<i>TUFM</i>)</div></li><li class="half_rhythm"><div>Leigh syndrome &#x00026; optic atrophy w/COX deficiency (<i>TACO1</i>)</div></li></ul>
</td></tr><tr><td headers="hd_h_mt-overview.T.genetic_classification_of_1_1_1_1" colspan="2" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Nuclear genetic disorders associated w/multiple mtDNA deletions or mtDNA depletion</b></td><td headers="hd_h_mt-overview.T.genetic_classification_of_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div><a href="/books/n/gene/alpers/">Autosomal progressive external ophthalmoplegia</a> (<i>POLG, POLG2, TWNK,</i>
<i>SLC25A4</i>)</div></li><li class="half_rhythm"><div><a href="/books/n/gene/mngie/">Mitochondrial neurogastrointestinal encephalomyopathy</a> (thymidine phosphorylase deficiency) (<i>TYMP</i>)</div></li><li class="half_rhythm"><div><a href="/books/n/gene/alpers/">Alpers-Huttenlocher syndrome</a> (<i>POLG</i>)</div></li><li class="half_rhythm"><div>Ataxia neuropathy syndromes&#x000a0;<sup>2</sup> (<i>POLG, TWNK, OPA1</i>)</div></li><li class="half_rhythm"><div><a href="/books/n/gene/tk2-mtddepl/">Infantile myopathy / spinal muscular atrophy</a> (<i>TK2</i>)</div></li><li class="half_rhythm"><div><a href="/books/n/gene/dguok-mtddepl/">Encephalomyopathy &#x00026; liver failure</a> (<i>DGUOK</i>)</div></li><li class="half_rhythm"><div><a href="/books/n/gene/sucla2-def/">Hypotonia, movement disorder, &#x00026;/or Leigh syndrome w/methylmalonic aciduria</a> (<i>SUCLA2</i>)</div></li><li class="half_rhythm"><div><a href="/books/n/gene/rrm2b-mtddepl/">Hypotonia, encephalopathy, renal tubulopathy, lactic acidosis</a> (<i>RRM2B</i>)</div></li><li class="half_rhythm"><div>Mitochondrial encephalomyopathy w/combined RC deficiency (<i>AIF1</i>)</div></li><li class="half_rhythm"><div>Reversible hepatopathy (<i>TRMU</i>)</div></li><li class="half_rhythm"><div>Myopathy with cataract &#x00026; combined RC deficiency (<i>GFER</i>)</div></li></ul>
</td></tr><tr><td headers="hd_h_mt-overview.T.genetic_classification_of_1_1_1_1" colspan="2" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Other disorders</b></td><td headers="hd_h_mt-overview.T.genetic_classification_of_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div><a href="/books/n/gene/coq10-def/">Coenzyme Q<sub>10</sub> deficiency</a> (<i>COQ2, COQ9, CABC1, ETFDH</i>)</div></li><li class="half_rhythm"><div><a href="/books/n/gene/barth/">Barth syndrome</a> (<i>TAZ</i>)</div></li><li class="half_rhythm"><div>Cardiomyopathy &#x00026; lactic acidosis (mitochondrial phosphate carrier deficiency) (<i>SLC25A3</i>)</div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">mt = mitochondrial</p></div></dd><dt>1. </dt><dd><div id="mt-overview.TF.3a.1"><p class="no_margin">See <a href="/books/n/gene/leigh-nucl-ov/">Nuclear Gene-Encoded Leigh Syndrome Overview</a>.</p></div></dd><dt>2. </dt><dd><div id="mt-overview.TF.3a.2"><p class="no_margin">Includes MIRAS, SCAE, SANDO, MEMSA</p></div></dd></dl></div></div></div><div id="mt-overview.T.genetic_classification_of_1" class="table"><h3><span class="label">Table 3b. </span></h3><div class="caption"><p>Genetic Classification of Human Mitochondrial Disorders: Mutation of Mitochondrial DNA</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1224/table/mt-overview.T.genetic_classification_of_1/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__mt-overview.T.genetic_classification_of_1_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_mt-overview.T.genetic_classification_of_1_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></th><th id="hd_h_mt-overview.T.genetic_classification_of_1_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mutation of Mitochondrial DNA</th></tr></thead><tbody><tr><td headers="hd_h_mt-overview.T.genetic_classification_of_1_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Rearrangements (deletions &#x00026; duplications)</b></td><td headers="hd_h_mt-overview.T.genetic_classification_of_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Chronic progressive external ophthalmoplegia</div></li><li class="half_rhythm"><div><a href="/books/n/gene/kss/">Kearns-Sayre syndrome</a></div></li><li class="half_rhythm"><div>Diabetes &#x00026; deafness</div></li></ul>
</td></tr><tr><td headers="hd_h_mt-overview.T.genetic_classification_of_1_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Single-nucleotide variants&#x000a0;<sup>1</sup></b></td><td headers="hd_h_mt-overview.T.genetic_classification_of_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Protein-encoding genes</div></li><li class="half_rhythm"><div><a href="/books/n/gene/lhon/">Leber hereditary optic neuropathy</a> (LHON) (m.11778G&#x0003e;A, m.14484T&#x0003e;C, m.3460G&#x0003e;A)</div></li><li class="half_rhythm"><div>Neurogenic weakness w/ataxia &#x00026; <a href="/books/n/gene/rp-overview/">retinitis pigmentosa</a> / <a href="/books/n/gene/narp/">Leigh syndrome</a> (m.8993T&#x0003e;G, m.8993T&#x0003e;C)</div></li></ul>
</td></tr><tr><td headers="hd_h_mt-overview.T.genetic_classification_of_1_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>tRNA genes&#x000a0;<sup>1</sup></b></td><td headers="hd_h_mt-overview.T.genetic_classification_of_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div><a href="/books/n/gene/melas/">MELAS</a> (m.3243A&#x0003e;G, m.3271T&#x0003e;C, m.3251A&#x0003e;G)</div></li><li class="half_rhythm"><div><a href="/books/n/gene/merrf/">MERRF</a> (m.8344A&#x0003e;G, m.8356T&#x0003e;C)</div></li><li class="half_rhythm"><div>Chronic progressive external ophthalmoplegia (m.3243A&#x0003e;G, m.4274T&#x0003e;C)</div></li><li class="half_rhythm"><div>Myopathy (m.14709T&#x0003e;C, m.12320A&#x0003e;G)</div></li><li class="half_rhythm"><div>Cardiomyopathy (m.3243A&#x0003e;G, m.4269A&#x0003e;G)</div></li><li class="half_rhythm"><div>Diabetes &#x00026; deafness (m.3243A&#x0003e;G, m.12258C&#x0003e;A)</div></li><li class="half_rhythm"><div>Encephalomyopathy (m.1606G&#x0003e;A, m.10010T&#x0003e;C)</div></li><li class="half_rhythm"><div><a href="/books/n/gene/mt-deafness/">Nonsyndromic sensorineural deafness</a> (m.7445A&#x0003e;G)</div></li></ul>
</td></tr><tr><td headers="hd_h_mt-overview.T.genetic_classification_of_1_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>rRNA genes&#x000a0;<sup>1</sup></b></td><td headers="hd_h_mt-overview.T.genetic_classification_of_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Aminoglycoside-induced nonsyndromic deafness (m.1555A&#x0003e;G)</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">For the genetic code, <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> structure, and other features of the mitochondrial genome see <a href="http://www.mitomap.org/MITOMAP" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MITOMAP: A Human Mitochondrial Genome Database</a>. Variants are named according to current nomenclature guidelines (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). The reference sequence for the human mitochondrial DNA is NC_012920.1 (<a href="http://www.mitomap.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www<wbr style="display:inline-block"></wbr>​.mitomap.org</a>).</p></div></dd><dt>1. </dt><dd><div id="mt-overview.TF.3b.1"><p class="no_margin">Mitochondrial DNA nucleotide positions refer to the L-chain.</p></div></dd></dl></div></div></div></div><div id="mt-overview.Establishing_the_Diagnosis_o"><h2 id="_mt-overview_Establishing_the_Diagnosis_o_">Establishing the Diagnosis of a Mitochondrial Disorder</h2><p>Mitochondrial dysfunction should be considered in the differential diagnosis of any progressive multisystem disorder. A full evaluation for a mitochondrial disorder is often warranted in children with a complex neurologic picture or a single neurologic symptom and other system involvement.</p><p>Findings that can suggest a mitochondrial disorder include clinical <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> (physical examination including neurologic examination), <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a> (family history), and extent of the phenotype (biochemical and histologic findings). Molecular genetic testing of DNA extracted from a blood sample is used to establish the diagnosis.</p><div id="mt-overview.Physical_Examination_and_Neu"><h3>Physical Examination and Neurologic Evaluation</h3><p><b>Approach when a specific diagnosis is suspected.</b> Establishing the diagnosis of a specific inherited disorder that affects mitochondrial function can be relatively straightforward if a person has a recognizable <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> (<a class="figpopup" href="/books/NBK1224/table/mt-overview.T.clinical_syndromes_of_mito/?report=objectonly" target="object" rid-figpopup="figmtoverviewTclinicalsyndromesofmito" rid-ob="figobmtoverviewTclinicalsyndromesofmito">Table 1</a>) that is supported by the family history and if <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> of a single <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> based on these phenotypic findings identifies a known <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the gene of interest.</p><ul><li class="half_rhythm"><div>When the clinical picture is classic for a nuclear DNA-inherited syndrome (<a class="figpopup" href="/books/NBK1224/table/mt-overview.T.genetic_classification_of/?report=objectonly" target="object" rid-figpopup="figmtoverviewTgeneticclassificationof" rid-ob="figobmtoverviewTgeneticclassificationof">Table 3a</a>) and the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> is known (e.g., <a href="/books/n/gene/mngie/">mitochondrial neurogastrointestinal encephalomyopathy</a>, <a class="def" href="/books/n/gene/glossary/def-item/autosomal/">autosomal</a> PEO with multiple secondary deletions, or a classic <a href="/books/n/gene/alpers/"><i>POLG</i>-related disorder</a> [including MIRAS and Alpers-Huttenlocher syndrome]) the clinician should proceed with molecular genetic studies (see <a href="#mt-overview.Molecular_Genetic_Testing">Molecular Genetic Testing</a>).</div></li><li class="half_rhythm"><div>When the presentation is classic for a maternally (mitochondrial) inherited mitochondrial syndrome such as <a href="/books/n/gene/melas/">MELAS</a>, <a href="/books/n/gene/merrf/">MERRF</a>, or <a href="/books/n/gene/lhon/">Leber hereditary optic neuropathy</a> (<a class="figpopup" href="/books/NBK1224/table/mt-overview.T.genetic_classification_of_1/?report=objectonly" target="object" rid-figpopup="figmtoverviewTgeneticclassificationof1" rid-ob="figobmtoverviewTgeneticclassificationof1">Table 3b</a>), appropriate mtDNA studies should be obtained first (see <a href="#mt-overview.Molecular_Genetic_Testing">Molecular Genetic Testing</a>).</div></li></ul></div><div id="mt-overview.Family_History"><h3>Family History</h3><p>A three-generation family history can suggest a <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a> and/or a diagnosis and can help in directing <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p><div id="mt-overview.Mode_of_Inheritance"><h4>Mode of Inheritance</h4><p><b>Mitochondrial inheritance</b> (<a class="figpopup" href="/books/NBK1224/table/mt-overview.T.genetic_classification_of_1/?report=objectonly" target="object" rid-figpopup="figmtoverviewTgeneticclassificationof1" rid-ob="figobmtoverviewTgeneticclassificationof1">Table 3b</a>). A family history in which males and females are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, affected females transmit the disease to all their children, and affected males do not transmit the disease to their children suggests <a class="def" href="/books/n/gene/glossary/def-item/mitochondrial-inheritance/">mitochondrial inheritance</a>.</p><p>The range of clinical features associated with mtDNA mutation is broad and the family history may include many oligosymptomatic family members (e.g., some with diabetes mellitus or mild sensorineural deafness as the only feature).</p><p><b>Autosomal recessive inheritance</b> (<a class="figpopup" href="/books/NBK1224/table/mt-overview.T.genetic_classification_of/?report=objectonly" target="object" rid-figpopup="figmtoverviewTgeneticclassificationof" rid-ob="figobmtoverviewTgeneticclassificationof">Table 3a</a>). A family history in which only sibs are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> (i.e., a single generation in the family) and/or when the parents are <a class="def" href="/books/n/gene/glossary/def-item/consanguineous/">consanguineous</a> suggests <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> inheritance.</p><p><b>Autosomal dominant inheritance</b> (<a class="figpopup" href="/books/NBK1224/table/mt-overview.T.genetic_classification_of/?report=objectonly" target="object" rid-figpopup="figmtoverviewTgeneticclassificationof" rid-ob="figobmtoverviewTgeneticclassificationof">Table 3a</a>). A family history in which males and females in multiple generations are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> suggests <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> inheritance.</p><p>A clear <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> pattern of inheritance may be seen in individuals with PEO.</p><p><b><a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> inheritance</b>. A family history in which <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals are male and are related to each other through females suggests X-linked inheritance.</p><p><b>Simplex case.</b> If only one member of a family is known to be <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, possibilities to consider are <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> mutation, decreased <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> of a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> associated with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> mitochondrial disorder, a single occurrence of an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> or an <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> disorder in a family, or an acquired (non-genetic) cause.</p><ul><li class="half_rhythm"><div>Most adults with PEO or KSS represent <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases.</div></li><li class="half_rhythm"><div>Many individuals with a childhood-onset encephalomyopathy represent <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases which may be caused by the presence of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in a nuclear <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> or a mtDNA <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li></ul><p>See the <a href="/books/NBK5191/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri"><i>GeneReviews</i> Glossary</a> for more discussion of mitochondrial, <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>, <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>, and <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> patterns of inheritance.</p><p><b>Approach when a mitochondrial disorder is suspected, but clinical findings do not suggest a specific diagnosis.</b> The difficulty arises when no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is identified (despite suspicion of a specific disorder) or when the clinical abnormalities are complex and not easily matched to those of more common mitochondrial disorders.</p><p>Clinical tests are used to support a diagnosis of mitochondrial disease [<a class="bk_pop" href="#mt-overview.REF.kaufmann.2009.85">Kaufmann et al 2009</a>].</p></div></div><div id="mt-overview.Other_Investigations_to_Esta"><h3>Other Investigations to Establish the Extent of the Phenotype</h3><p>When the clinical picture is nonspecific but highly suggestive of a mitochondrial disorder, the clinician should start with measurement of plasma or CSF lactic acid concentration, ketone bodies, plasma acylcarnitines, and urinary organic acids.</p><p><b>Plasma/CSF Lactate/pyruvate</b></p><ul><li class="half_rhythm"><div class="half_rhythm">Measurement of plasma lactate concentration is indicated in individuals with features of a myopathy or CNS disease. Fasting blood lactate concentrations above 3 mm/L support a diagnosis of mitochondrial disease.</div></li><li class="half_rhythm"><div class="half_rhythm">Measurement of CSF lactate concentration is indicated in individuals with suspected CNS disease. Fasting CSF lactate concentrations above 1.5 mm/L support a diagnosis of mitochondrial disease.</div><div class="half_rhythm">Note: Normal plasma or CSF lactic acid concentration does not exclude the presence of a mitochondrial disorder.</div></li></ul><p><b>Magnetic resonance spectroscopy and exercise testing</b> may also be of use to detect an elevated lactate level in brain or muscle at rest, or a delay in the recovery of the ATP peak in muscle after exercise.</p><p><b>Neuroimaging</b> is indicated in individuals with suspected CNS disease. CT may show basal ganglia calcification and/or diffuse atrophy. MRI may show focal atrophy of the cortex or cerebellum, or high signal change on T<sub>2</sub>-weighted images, particularly in the occipital cortex [<a class="bk_pop" href="#mt-overview.REF.scaglia.2005.1675">Scaglia et al 2005</a>]. There may also be evidence of a generalized leukoencephalopathy [<a class="bk_pop" href="#mt-overview.REF.barrag_ncampos.2005.737">Barrag&#x000e1;n-Campos et al 2005</a>]. Cerebellar atrophy is a prominent feature in children [<a class="bk_pop" href="#mt-overview.REF.scaglia.2005.1675">Scaglia et al 2005</a>].</p><p><b>Neurophysiologic studies</b></p><ul><li class="half_rhythm"><div>Electroencephalography (EEG) is indicated in individuals with suspected encephalopathy or seizures. Encephalopathy may be associated with generalized slow wave activity on the EEG. Generalized or focal spike and wave discharges may be seen in individuals with seizures.</div></li><li class="half_rhythm"><div>Peripheral neurophysiologic studies are indicated in individuals with limb weakness, sensory symptoms, or areflexia. Electromyography (EMG) is often normal but may show myopathic features. Nerve conduction velocity (NCV) may be normal or may show a predominantly axonal sensorimotor polyneuropathy.</div></li><li class="half_rhythm"><div>Magnetic resonance spectroscopy (MRS) and exercise testing (with measurement of blood concentration of lactate) may be used to detect evidence of abnormal mitochondrial function non-invasively.</div></li></ul><p><b>Glucose.</b> An elevated concentration of fasting blood glucose may indicate diabetes mellitus.</p><p><b>Cardiac.</b> Both electrocardiography and echocardiography may indicate cardiac involvement (cardiomyopathy or atrioventricular conduction defects).</p></div><div id="mt-overview.Molecular_Genetic_Testing"><h3>Molecular Genetic Testing</h3><p>Establishing a molecular genetic diagnosis has important implications for the counseling of individuals with mitochondrial disease [<a class="bk_pop" href="#mt-overview.REF.lieber.2013.1762">Lieber et al 2013</a>, <a class="bk_pop" href="#mt-overview.REF.nesbitt.2013.936">Nesbitt et al 2013</a>]. For example, infantile cytochrome oxidase deficiency may be caused by <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in the nuclear genes <i>SURF1</i> or <i>SCO2</i> or by a maternally inherited single nucleotide variant of mtDNA (e.g., m.8993T&#x0003e;G). CPEO may be caused by a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> (e.g., caused by a large deletion of mtDNA) or maternally inherited (e.g., the mtDNA m.3243A&#x0003e;G <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</p><p>The ordering of molecular genetic tests and interpretation of results is complex and may require the support of an experienced laboratory, clinical geneticist, and genetic counselor.</p><p>Molecular genetic testing may be carried out on <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA extracted from blood (suspected nuclear DNA pathogenic variants and some pathogenic mtDNA variants) or on genomic DNA extracted from muscle (suspected pathogenic mtDNA variants).</p><p>Approaches to <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> to consider are serial testing of single genes, <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> testing (simultaneous testing of multiple genes), and <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing (e.g., sequencing the mitochondrial genome; <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> or <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a> to identify a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in a nuclear <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>).</p><div id="mt-overview.SingleGene_and_Multigene_Pan"><h4>Single-Gene and Multigene Panel Testing</h4><p>In contrast to <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing, serial testing of single genes and <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> testing rely on the clinician developing a hypothesis about which specific <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> or set of genes to test. Hypotheses may be based on (1) <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a>, (2) distinguishing clinical features, and/or (3) other discriminating features.</p><p><b>Studies for pathogenic mtDNA variants</b> are usually carried out on skeletal muscle DNA because a pathogenic mtDNA variant may not be detected in DNA extracted from blood.</p><ul><li class="half_rhythm"><div>Long-range <a class="def" href="/books/n/gene/glossary/def-item/pcr/">PCR</a> or <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a> analysis may reveal a pathogenic mtDNA rearrangement. The <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> or <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> breakpoint may then be mapped by mtDNA sequencing.</div></li><li class="half_rhythm"><div>Targeted analysis for pathogenic variants featuring a panel of mitochondrial genes may be performed.</div></li><li class="half_rhythm"><div>If a recognized single nucleotide variant is not identified, the entire mitochondrial genome may be sequenced.</div></li></ul><p><b>Studies for nuclear <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> pathogenic variants.</b> For multigene panels:</p><ul><li class="half_rhythm"><div>The genes included and the methods used in multigene panels vary by laboratory and are likely to change over time.</div></li><li class="half_rhythm"><div>The testing method used in some multigene panels may not detect mtDNA variants at low levels of <a class="def" href="/books/n/gene/glossary/def-item/heteroplasmy/">heteroplasmy</a> in blood, or mtDNA deletions and, therefore, would not be useful if a disorder (or disorders) caused by pathogenic mtDNA variants were suspected.</div></li></ul></div><div id="mt-overview.Genomic_Testing"><h4>Genomic Testing</h4><p>If single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing (and/or use of a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>) has not confirmed a diagnosis in an individual with features of a mitochondrial disorder, <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing may be considered. Such testing includes <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a>, <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a>, and mitochondrial sequencing.</p><p>Note: (1) False negative rates vary by <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> region; therefore, genomic testing may not be as accurate as targeted single <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing or multigene <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> panels. (2) Most laboratories confirm positive results using a second, well-established method. (3) Certain DNA variants may not be detectible through genomic testing, such as large deletions or duplications (&#x0003e;8-10 bp in length), triplet repeat expansions, and epigenetic alterations [<a class="bk_pop" href="#mt-overview.REF.biesecker.2014.2418">Biesecker &#x00026; Green 2014</a>].</p><p>Exome sequencing has been shown to be very effective in defining the genetic basis of mitochondrial disorders caused by mutation of nuclear genes [<a class="bk_pop" href="#mt-overview.REF.taylor.2014.68">Taylor et al 2014</a>]. To determine the molecular basis of multiple respiratory chain complex deficiencies, <a class="bk_pop" href="#mt-overview.REF.taylor.2014.68">Taylor et al [2014]</a> studied 53 individuals who met the following criteria:</p><ul><li class="half_rhythm"><div>Evidence of histochemical and/or biochemical diagnosis of mitochondrial disease in a clinically <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> tissue (skeletal muscle, liver, or heart) confirming decreased activities of multiple respiratory chain complexes based on published criteria</div></li><li class="half_rhythm"><div>Absence of large-scale mtDNA rearrangements, mtDNA depletion, and mtDNA single-nucleotide variants, in persons in whom decreased levels of mtDNA were confirmed in muscle (mtDNA depletion)</div></li><li class="half_rhythm"><div>Exclusion of major nuclear <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> rearrangements by <a class="def" href="/books/n/gene/glossary/def-item/comparative-genomic-hybridization/">comparative genomic hybridization</a> arrays in those with <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> structural abnormalities</div></li></ul><p>Of the 53 probands, presumptive causal variants were identified in 28 (53%; 95%CI, 39%-67%) and possible causal variants were identified in four (8%; 95%CI, 2%-18%). Together these accounted for 32 probands (60% 95%CI, 46%-74%) and involved 18 different genes.</p></div></div><div id="mt-overview.Other_NonMolecular_Genetic_T"><h3>Other (Non-Molecular Genetic) Testing</h3><p>In many individuals in whom <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> does not yield or confirm a diagnosis, further investigation of suspected mitochondrial disease can involve a range of different clinical tests, including muscle biopsy for respiratory chain function.</p></div></div><div id="mt-overview.Genetic_Counseling"><h2 id="_mt-overview_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="mt-overview.Mode_of_Inheritance_1"><h3>Mode of Inheritance</h3><p>Mitochondrial disorders may be caused by mutation of a mtDNA <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> or mutation of a nuclear gene.</p><ul><li class="half_rhythm"><div>Mitochondrial DNA variants are transmitted by maternal inheritance (<a class="def" href="/books/n/gene/glossary/def-item/mitochondrial-inheritance/">mitochondrial inheritance</a>) [<a class="bk_pop" href="#mt-overview.REF.thorburn.2001.102">Thorburn &#x00026; Dahl 2001</a>].</div></li><li class="half_rhythm"><div>Nuclear <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> variants may be inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>, <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>, or <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> manner.</div></li></ul></div><div id="mt-overview.Risk_to_Family_Members__Mito"><h3>Risk to Family Members &#x02013; Mitochondrial Inheritance</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Single mtDNA deletions</div><ul><li class="half_rhythm"><div>Mitochondrial DNA deletions generally occur <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> and thus affect only one family member.</div></li><li class="half_rhythm"><div>When single mtDNA deletions are transmitted, inheritance is from the mother.</div></li><li class="half_rhythm"><div>The predisposition to form multiple mtDNA deletions can be inherited as an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> or an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> trait.</div></li></ul></li><li class="half_rhythm"><div>Mitochondrial DNA single-nucleotide variants and duplications</div><ul><li class="half_rhythm"><div>Mitochondrial DNA single-nucleotide variants and duplications may be transmitted through the maternal line.</div></li><li class="half_rhythm"><div>The father of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is not at risk of having the mtDNA <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>The mother of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> (usually) has the mtDNA <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> and may or may not have symptoms.</div></li></ul></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The risk to the sibs depends on the genetic status of the mother: if the mother has the mtDNA <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, all sibs are at risk of inheriting it.</div></li><li class="half_rhythm"><div>When a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has a single mtDNA <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>, the current best estimate of the <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> to sibs is 1/24 [<a class="bk_pop" href="#mt-overview.REF.chinnery.2004.592">Chinnery et al 2004</a>].</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Offspring of males with a mtDNA <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> will not inherit the variant.</div></li><li class="half_rhythm"><div>All offspring of females with a mtDNA <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> are at risk of inheriting the pathogenic variant.</div><ul><li class="half_rhythm"><div>A female harboring a <a class="def" href="/books/n/gene/glossary/def-item/heteroplasmic/">heteroplasmic</a> mtDNA single nucleotide variant may transmit a variable amount of mutated mtDNA to her offspring, resulting in considerable clinical variability among sibs within the same nuclear family [<a class="bk_pop" href="#mt-overview.REF.poulton.2000.460">Poulton &#x00026; Turnbull 2000</a>].</div></li><li class="half_rhythm"><div>For the m.8993T&#x0003e;G, m.8993T&#x0003e;C, m.3243A&#x0003e;G, m.8344A&#x0003e;G, and m.11778G&#x0003e;A mtDNA pathogenic variants, the risk of having clinically <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> offspring appears to be related to the percentage level of mutated mtDNA in the mother's blood [<a class="bk_pop" href="#mt-overview.REF.chinnery.1998.1889">Chinnery et al 1998</a>, <a class="bk_pop" href="#mt-overview.REF.white.1999a.474">White et al 1999a</a>, <a class="bk_pop" href="#mt-overview.REF.chinnery.2001.235">Chinnery et al 2001</a>]. However, these data were obtained retrospectively and should not be directly used for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a>.</div></li></ul></li></ul><p><b>Other family members of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to other family members depends on the genetic status of the proband's mother: if she has a mtDNA <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, her sibs and mother are also at risk.</p></div><div id="mt-overview.Risk_to_Family_Members__Auto"><h3>Risk to Family Members &#x02013; Autosomal Recessive Inheritance</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child are obligate heterozygotes and therefore each carry one <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, the sibs of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual have a 25% chance of inheriting both pathogenic variants and being affected, a 50% chance of inheriting one <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> and being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of inheriting both normal alleles and being unaffected.</div></li><li class="half_rhythm"><div>Once an at-risk sib is known to be unaffected, the risk of his/her being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> is 2/3.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> All offspring are obligate heterozygotes.</p></div><div id="mt-overview.Risk_to_Family_Members__Auto_1"><h3>Risk to Family Members &#x02013; Autosomal Dominant Inheritance</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>One parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> may have the same <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> as the proband; that parent may or may not have symptoms.</div></li><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> may have the disorder as the result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. The proportion of cases caused by a <i>de novo</i> pathogenic variant is unknown.</div></li></ul><p>Note: The family history may appear to be negative because of failure to recognize the disorder in family members, early death of the parent before the onset of symptoms, or late onset of the disease in the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent.</p><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to the sibs depends on the genetic status of the parents: if one parent has the same <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the risk to the sibs is 50%.</p><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each offspring of a proband has a 50% chance of inheriting the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div><div id="mt-overview.Risk_to_Family_Members__XLin"><h3>Risk to Family Members &#x02013; X-Linked Inheritance</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The father of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> male will not have the disease nor will he be a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>Women who have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> son and another affected male relative are obligate heterozygotes.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to sibs depends on the <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status of the mother:</p><ul><li class="half_rhythm"><div>If the mother of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the chance of transmitting it in each pregnancy is 50%. Male sibs who inherit the pathogenic variant will be <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>; female sibs who inherit the pathogenic variant will be carriers and will usually not be affected.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> represents a <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> case (i.e., a single occurrence in a family) and if the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> cannot be detected in the leukocyte DNA of the mother, the risk to sibs is low but greater than that of the general population because of the possibility of maternal <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> All the daughters of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> male are carriers; none of his sons will be affected.</p></div><div id="mt-overview.Related_Genetic_Counseling_I"><h3>Related Genetic Counseling Issues</h3><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="mt-overview.Prenatal_Testing"><h3>Prenatal Testing</h3><p><b>Mutation of mitochondrial DNA (mtDNA).</b> Prenatal <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> and interpretation for mtDNA disorders is difficult because of mtDNA <a class="def" href="/books/n/gene/glossary/def-item/heteroplasmy/">heteroplasmy</a>. The percentage level of mutated mtDNA in a chorionic villus sampling (CVS) biopsy may not reflect the percentage level of mutated mtDNA in other fetal tissues, and the percentage level may change during development and throughout life [<a class="bk_pop" href="#mt-overview.REF.hellebrekers.2012.341">Hellebrekers et al 2012</a>].</p><p>The interpretation of a CVS result is difficult for most <a class="def" href="/books/n/gene/glossary/def-item/heteroplasmic/">heteroplasmic</a> mtDNA pathogenic variants. However, the variants m.8993T&#x0003e;G and m.8993T&#x0003e;C show a more even tissue distribution and the percentage level of these two variants does not appear to change significantly over time [<a class="bk_pop" href="#mt-overview.REF.white.1999b.899">White et al 1999b</a>]. Successful prenatal molecular diagnosis has been carried out for these two pathogenic variants [<a class="bk_pop" href="#mt-overview.REF.harding.1992.629">Harding et al 1992</a>, <a class="bk_pop" href="#mt-overview.REF.white.1999a.474">White et al 1999a</a>] using DNA extracted from fetal cells obtained by amniocentesis (usually performed at ~15-18 weeks' gestation) or CVS (usually performed at ~10-12 weeks' gestation) [<a class="bk_pop" href="#mt-overview.REF.hellebrekers.2012.341">Hellebrekers et al 2012</a>].</p><p><b>Mutation of nuclear DNA</b></p><ul><li class="half_rhythm"><div><b>Molecular genetic testing.</b> Once the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>(s) have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk is possible.</div></li><li class="half_rhythm"><div><b>Biochemical genetic testing.</b> Once the specific biochemical abnormality has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal biochemical testing for pregnancies at risk for respiratory chain complex defects is possible using biochemical testing of cultured amniocytes obtained from amniocentesis usually performed at about 15 to 18 weeks' gestation [<a class="bk_pop" href="#mt-overview.REF.poulton.2000.460">Poulton &#x00026; Turnbull 2000</a>].</div></li></ul><p><b>Preimplantation genetic diagnosis (PGD)</b> may be an option for some families in which the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>(s) have been identified.</p></div></div><div id="mt-overview.Resources"><h2 id="_mt-overview_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>National Library of Medicine Genetics Home Reference</b></div><div><a href="http://ghr.nlm.nih.gov/condition=leberhereditaryopticneuropathy" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Leber hereditary optic neuropathy</a></div></li><li class="half_rhythm"><div><b>National Library of Medicine Genetics Home Reference</b></div><div><a href="http://ghr.nlm.nih.gov/condition=mitochondrialencephalomyopathylacticacidosisandstrokelikeepisodes" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri"> Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes</a></div></li><li class="half_rhythm"><div><b>National Library of Medicine Genetics Home Reference</b></div><div><a href="http://ghr.nlm.nih.gov/condition=neuropathyataxiaandretinitispigmentosa" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Neuropathy, ataxia, and retinitis pigmentosa</a></div></li><li class="half_rhythm"><div><b>United Mitochondrial Disease Foundation (UMDF)</b></div><div>8085 Saltsburg Road</div><div>Suite 201</div><div>Pittsburg PA 15239</div><div><b>Phone:</b> 888-317-8633 (toll-free); 412-793-8077</div><div><b>Fax:</b> 412-793-6477</div><div><b>Email:</b> info@umdf.org</div><div><a href="http://www.umdf.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.umdf.org</a></div></li><li class="half_rhythm"><div><b>International Foundation for Optic Nerve Disease (IFOND)</b></div><div>PO Box 777</div><div>Cornwall NY 12518</div><div><b>Phone:</b> 845-534-7250</div><div><b>Fax:</b> 845-534-7250</div><div><b>Email:</b> ifond@aol.com</div><div><a href="http://www.ifond.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ifond.org</a></div></li><li class="half_rhythm"><div><b>Mito Foundation (formerly the Australian Mitochondrial Disease Foundation)</b></div><div>21 Mary Street</div><div>Suite 3</div><div>Surry Hills New South Wales 2010</div><div>Australia</div><div><b>Phone:</b> 61-1-300-977-180</div><div><b>Fax:</b> 61-2-9999-3474</div><div><b>Email:</b> info@mito.org.au</div><div><a href="https://www.mito.org.au/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.mito.org.au</a></div></li><li class="half_rhythm"><div><b>Muscular Dystrophy Association - USA (MDA)</b></div><div>222 South Riverside Plaza</div><div>Suite 1500</div><div>Chicago IL 60606</div><div><b>Phone:</b> 800-572-1717</div><div><b>Email:</b> mda@mdausa.org</div><div><a href="http://www.mda.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.mda.org</a></div></li><li class="half_rhythm"><div><b>The Lily Foundation</b></div><div>31 Warren Park</div><div>Surrey CR6 9LD</div><div>United Kingdom</div><div><b>Phone:</b> 07947 257247</div><div><b>Fax:</b> 01883 623799</div><div><b>Email:</b> liz@thelilyfoundation.org.uk</div><div><a href="http://www.thelilyfoundation.org.uk/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.thelilyfoundation.org.uk</a></div></li><li class="half_rhythm"><div><b>Mitochondrial Disease Registry and Tissue Bank</b></div><div>Massachusetts General Hospital</div><div>185 Cambridge Street</div><div>Simches Research Building 5-238</div><div>Boston MA 02114</div><div><b>Phone:</b> 617-726-5718</div><div><b>Fax:</b> 617-724-9620</div><div><b>Email:</b> nslate@partners.org</div></li><li class="half_rhythm"><div><b>RDCRN Patient Contact Registry: North American Mitochondrial Disease Consortium</b></div><div><a href="https://www.rarediseasesnetwork.org/cms/namdc" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Patient Contact Registry</a></div></li></ul></div><div id="mt-overview.Management"><h2 id="_mt-overview_Management_">Management</h2><div id="mt-overview.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>The management of mitochondrial disease is largely supportive [<a class="bk_pop" href="#mt-overview.REF.chinnery.2001.94">Chinnery &#x00026; Turnbull 2001</a>]. The clinician must have a thorough knowledge of the potential complications of mitochondrial disorders to prevent unnecessary morbidity and mortality.</p><p>Management issues may include early diagnosis and treatment of diabetes mellitus, cardiac pacing, ptosis correction, intraocular lens replacement for cataracts, and cochlear implantation for sensorineural hearing loss.</p><p>A variety of vitamins and co-factors have been used in individuals with mitochondrial disorders, although a Cochrane systematic review has shown that evidence supporting their use is lacking [<a class="bk_pop" href="#mt-overview.REF.chinnery.2006.cd004426">Chinnery et al 2006</a>].</p><ul><li class="half_rhythm"><div>Food supplements such as ubiquinone (coenzyme Q<sub>10</sub>, ubidecarenone) are generally well tolerated and some individuals report a subjective benefit on treatment.</div></li><li class="half_rhythm"><div>Individuals with complex I and/or complex II deficiency may benefit from oral administration of riboflavin.</div></li></ul><p>The role of exercise therapy in mitochondrial myopathy is currently being evaluated [<a class="bk_pop" href="#mt-overview.REF.taivassalo.2001.133">Taivassalo et al 2001</a>, <a class="bk_pop" href="#mt-overview.REF.taivassalo.2006.3391">Taivassalo et al 2006</a>, <a class="bk_pop" href="#mt-overview.REF.murphy.2008.2832">Murphy et al 2008</a>].</p><p>Coenzyme Q<sub>10</sub> is specifically indicated in persons with defects of CoQ<sub>10</sub> biosynthesis.</p><p>Idebenone shows promise for the treatment of <a href="/books/n/gene/lhon/">Leber hereditary optic neuropathy</a>.</p><p>Some secondary causes of mitochondrial dysfunction, such as <a href="/books/n/gene/ee/">ethylmalonic aciduria</a>, may have specific treatments [<a class="bk_pop" href="#mt-overview.REF.tiranti.2009.200">Tiranti et al 2009</a>].</p><p>Those with <a href="/books/n/gene/mngie/">mitochondrial neurogastrointestinal encephalomyopathy</a> (MNGIE) may benefit from hematopoietic stem cell transplantation.</p></div><div id="mt-overview.Prevention_Strategies_Under"><h3>Prevention Strategies Under Investigation</h3><p>The possibility of nuclear transfer as a means of preventing transmission of pathogenic mtDNA variants is currently being explored [<a class="bk_pop" href="#mt-overview.REF.craven.2010.82">Craven et al 2010</a>].</p></div></div><div id="mt-overview.References"><h2 id="_mt-overview_References_">References</h2><div id="mt-overview.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="mt-overview.REF.arpa.2003.690">Arpa J, Cruz-Martinez A, Campos Y, Gutierrez-Molina M, Garcia-Rio F, Perez-Conde C, Martin MA, Rubio JC, Del Hoyo P, Arpa-Fernandez A, Arenas J. Prevalence and progression of mitochondrial diseases: a study of 50 patients. <span><span class="ref-journal">Muscle Nerve. </span>2003;<span class="ref-vol">28</span>:690–5.</span> [<a href="/pubmed/14639582" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14639582</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mt-overview.REF.barrag_ncampos.2005.737">Barrag&#x000e1;n-Campos HM, Vallee JN, Lo D, Barrera-Ramirez CF, Argote-Greene M, Sanchez-Guerrero J, Estanol B, Guillevin R, Chiras J. Brain magnetic resonance imaging findings in patients with mitochondrial cytopathies. <span><span class="ref-journal">Arch Neurol. </span>2005;<span class="ref-vol">62</span>:737–42.</span> [<a href="/pubmed/15883260" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15883260</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mt-overview.REF.biesecker.2014.2418">Biesecker LG, Green RC. Diagnostic clinical genome and exome sequencing. <span><span class="ref-journal">N Engl J Med. </span>2014 Jun 19;<span class="ref-vol">370</span>(25):2418–25.</span> [<a href="/pubmed/24941179" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24941179</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mt-overview.REF.casari.1998.973">Casari G, De Fusco M, Ciarmatori S, Zeviani M, Mora M, Fernandez P, De Michele G, Filla A, Cocozza S, Marconi R, D&#x000fc;rr A, Fontaine B, Ballabio A. Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease. <span><span class="ref-journal">Cell. </span>1998;<span class="ref-vol">93</span>:973–83.</span> [<a href="/pubmed/9635427" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9635427</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mt-overview.REF.chinnery.2001.235">Chinnery PF, Andrews RM, Turnbull DM, Howell NN. Leber hereditary optic neuropathy: Does heteroplasmy influence the inheritance and expression of the G11778A mitochondrial DNA mutation? <span><span class="ref-journal">Am J Med Genet. </span>2001;<span class="ref-vol">98</span>:235–43.</span> [<a href="/pubmed/11169561" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11169561</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mt-overview.REF.chinnery.2004.592">Chinnery PF, DiMauro S, Shanske S, Schon EA, Zeviani M, Mariotti C, Carrara F, Lombes A, Laforet P, Ogier H, Jaksch M, Lochm&#x000fc;ller H, Horvath R, Deschauer M, Thorburn DR, Bindoff LA, Poulton J, Taylor RW, Matthews JN, Turnbull DM. Risk of developing a mitochondrial DNA deletion disorder. <span><span class="ref-journal">Lancet. </span>2004;<span class="ref-vol">364</span>:592–6.</span> [<a href="/pubmed/15313359" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15313359</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mt-overview.REF.chinnery.1998.1889">Chinnery PF, Howell N, Lightowlers RN, Turnbull DM. MELAS and MERRF. The relationship between maternal mutation load and the frequency of clinically affected offspring. <span><span class="ref-journal">Brain. </span>1998;<span class="ref-vol">121</span>:1889–94.</span> [<a href="/pubmed/9798744" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9798744</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mt-overview.REF.chinnery.2000.188">Chinnery PF, Johnson MA, Wardell TM, Singh-Kler R, Hayes C, Brown DT, Taylor RW, Bindoff LA, Turnbull DM. The epidemiology of pathogenic mitochondrial DNA mutations. <span><span class="ref-journal">Ann Neurol. </span>2000;<span class="ref-vol">48</span>:188–93.</span> [<a href="/pubmed/10939569" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10939569</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mt-overview.REF.chinnery.2006.cd004426">Chinnery P, Majamaa K, Turnbull D, Thorburn D. Treatment for mitochondrial disorders. <span><span class="ref-journal">Cochrane Database Syst Rev. </span>2006;<span class="ref-vol">1</span>:CD004426.</span> [<a href="/pubmed/16437486" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16437486</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mt-overview.REF.chinnery.2001.94">Chinnery PF, Turnbull DM. Epidemiology and treatment of mitochondrial disorders. <span><span class="ref-journal">Am J Med Genet. </span>2001;<span class="ref-vol">106</span>:94–101.</span> [<a href="/pubmed/11579428" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11579428</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mt-overview.REF.ciafaloni.1993.419">Ciafaloni E, Santorelli FM, Shanske S, Deonna T, Roulet E, Janzer C, Pescia G, DiMauro S. Maternally inherited Leigh syndrome. <span><span class="ref-journal">J Pediatr. </span>1993;<span class="ref-vol">122</span>:419–22.</span> [<a href="/pubmed/8095070" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8095070</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mt-overview.REF.craven.2010.82">Craven L, Tuppen HA, Greggains GD, Harbottle SJ, Murphy JL, Cree LM, Murdoch AP, Chinnery PF, Taylor RW, Lightowlers RN, Herbert M, Turnbull DM. Pronuclear transfer in human embryos to prevent transmission of mitochondrial DNA disease. <span><span class="ref-journal">Nature. </span>2010;<span class="ref-vol">465</span>:82–5.</span> [<a href="/pmc/articles/PMC2875160/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2875160</span></a>] [<a href="/pubmed/20393463" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20393463</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mt-overview.REF.darin.2001.377">Darin N, Oldfors A, Moslemi AR, Holme E, Tulinius M. The incidence of mitochondrial encephalomyopathies in childhood: clinical features and morphological, biochemical, and DNA anbormalities. <span><span class="ref-journal">Ann Neurol. </span>2001;<span class="ref-vol">49</span>:377–83.</span> [<a href="/pubmed/11261513" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11261513</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mt-overview.REF.dimauro.2001.18">DiMauro S, Schon EA. Mitochondrial DNA mutations in human disease. <span><span class="ref-journal">Am J Med Genet. </span>2001;<span class="ref-vol">106</span>:18–26.</span> [<a href="/pubmed/11579421" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11579421</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mt-overview.REF.hammans.1993.617">Hammans SR, Sweeney MG, Brockington M, Lennox GG, Lawton NF, Kennedy CR, Morgan-Hughes JA, Harding AE. The mitochondrial DNA transfer RNA(Lys)A--&#x0003e;G(8344) mutation and the syndrome of myoclonic epilepsy with ragged red fibres (MERRF). Relationship of clinical phenotype to proportion of mutant mitochondrial DNA. <span><span class="ref-journal">Brain. </span>1993;<span class="ref-vol">116</span>:617–32.</span> [<a href="/pubmed/8513395" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8513395</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mt-overview.REF.harding.1992.629">Harding AE, Holt IJ, Sweeney MG, Brockington M, Davis MB. Prenatal diagnosis of mitochondrial DNA8993 T----G disease. <span><span class="ref-journal">Am J Hum Genet. </span>1992;<span class="ref-vol">50</span>:629–33.</span> [<a href="/pmc/articles/PMC1684296/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1684296</span></a>] [<a href="/pubmed/1539598" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1539598</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mt-overview.REF.hellebrekers.2012.341">Hellebrekers DM, Wolfe R, Hendrickx AT, de Coo IF, de Die CE, Geraedts JP, Chinnery PF, Smeets HJ. PGD and heteroplasmic mitochondrial DNA point mutations: a systematic review estimating the chance of healthy offspring. <span><span class="ref-journal">Human Reproduction Update. </span>2012;<span class="ref-vol">18</span>:341–9.</span> [<a href="/pubmed/22456975" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22456975</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mt-overview.REF.hirano.1992.125">Hirano M, Ricci E, Koenigsberger MR, Defendini R, Pavlakis SG, DeVivo DC, DiMauro S, Rowland LP. Melas: an original case and clinical criteria for diagnosis. <span><span class="ref-journal">Neuromuscul Disord. </span>1992;<span class="ref-vol">2</span>:125–35.</span> [<a href="/pubmed/1422200" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1422200</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mt-overview.REF.holt.1988.717">Holt IJ, Harding AE, Morgan-Hughes JA. Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. <span><span class="ref-journal">Nature. </span>1988;<span class="ref-vol">331</span>:717–9.</span> [<a href="/pubmed/2830540" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2830540</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mt-overview.REF.holt.1990.428">Holt IJ, Harding AE, Petty RK, Morgan-Hughes JA. A new mitochondrial disease associated with mitochondrial DNA heteroplasmy. <span><span class="ref-journal">Am J Hum Genet. </span>1990;<span class="ref-vol">46</span>:428–33.</span> [<a href="/pmc/articles/PMC1683641/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1683641</span></a>] [<a href="/pubmed/2137962" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2137962</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mt-overview.REF.kaufmann.2009.85">Kaufmann P, Engelstad K, Wei Y, Kulikova R, Oskoui M, Battista V, Koenigsberger DY, Pascual JM, Sano M, Hirano M, DiMauro S, Shungu DC, Mao X, De Vivo DC. Protean phenotypic features of the A3243G mitochondrial DNA mutation. <span><span class="ref-journal">Arch Neurol. </span>2009;<span class="ref-vol">66</span>:85–91.</span> [<a href="/pubmed/19139304" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19139304</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mt-overview.REF.koopman.2012.1132">Koopman WJ, Willems PH, Smeitink JA. Monogenic mitochondrial disorders. <span><span class="ref-journal">N Engl J Med. </span>2012;2012;<span class="ref-vol">366</span>:1132–41.</span> [<a href="/pubmed/22435372" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22435372</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mt-overview.REF.larsson.1995.151">Larsson NG, Clayton DA. Molecular genetic aspects of human mitochondrial disorders. <span><span class="ref-journal">Annu Rev Genet. </span>1995;<span class="ref-vol">29</span>:151–78.</span> [<a href="/pubmed/8825472" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8825472</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mt-overview.REF.leonard.2000a.299">Leonard JV, Schapira AVH. Mitochondrial respiratory chain disorders I: mitochondrial DNA defects. <span><span class="ref-journal">Lancet. </span>2000a;<span class="ref-vol">355</span>:299–304.</span> [<a href="/pubmed/10675086" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10675086</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mt-overview.REF.leonard.2000b.389">Leonard JV, Schapira AVH. Mitochondrial respiratory chain disorders II: neurodegenerative disorders and nuclear gene defects. <span><span class="ref-journal">Lancet. </span>2000b;<span class="ref-vol">355</span>:389–94.</span> [<a href="/pubmed/10665569" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10665569</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mt-overview.REF.lieber.2013.1762">Lieber DS, Calvo SE, Shanahan K, Slate NG, Liu S, Hershman SG, Gold NB, Chapman BA, Thorburn DR, Berry GT, Schmahmann JD, Borowsky ML, Mueller DM, Sims KB, Mootha VK. Targeted exome sequencing of suspected mitochondrial disorders. <span><span class="ref-journal">Neurology. </span>2013;<span class="ref-vol">80</span>:1762–70.</span> [<a href="/pmc/articles/PMC3719425/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3719425</span></a>] [<a href="/pubmed/23596069" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23596069</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mt-overview.REF.lutsenko.1998.6004">Lutsenko S, Cooper MJ. Localization of the Wilson's disease protein product to mitochondria. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>1998;<span class="ref-vol">95</span>:6004–9.</span> [<a href="/pmc/articles/PMC27575/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC27575</span></a>] [<a href="/pubmed/9600907" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9600907</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mt-overview.REF.macmillan.1993.1586">Macmillan C, Lach B, Shoubridge EA. Variable distribution of mutant mitochondrial DNAs (tRNA(Leu[3243])) in tissues of symptomatic relatives with MELAS: the role of mitotic segregation. <span><span class="ref-journal">Neurology. </span>1993;<span class="ref-vol">43</span>:1586–90.</span> [<a href="/pubmed/8351017" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8351017</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mt-overview.REF.majamaa.1998.447">Majamaa K, Moilanen JS, Uimonen S, Remes AM, Salmela PI, Karppa M, Majamaa-Voltti KA, Rusanen H, Sorri M, Peuhkurinen KJ, Hassinen IE. Epidemiology of A3243G, the mutation for mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes: prevalence of the mutation in an adult population. <span><span class="ref-journal">Am J Hum Genet. </span>1998;<span class="ref-vol">63</span>:447–54.</span> [<a href="/pmc/articles/PMC1377301/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1377301</span></a>] [<a href="/pubmed/9683591" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9683591</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mt-overview.REF.moraes.1989.1293">Moraes CT, DiMauro S, Zeviani M, Lombes A, Shanske S, Miranda AF, Nakase H, Bonilla E, Werneck LC, Servidei S, Nonaka I, Koga Y, Spiro AJ, Brownell AKW, Schmidt B, Schotland DL, Zupanc M, DeVivo DC, Schon EA, Rowland LP. Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome. <span><span class="ref-journal">N Engl J Med. </span>1989;<span class="ref-vol">320</span>:1293–9.</span> [<a href="/pubmed/2541333" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2541333</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mt-overview.REF.morat_.2014.1878">Morat&#x000f3; L, Bertini E, Verrigni D, Ardissone A, Ruiz M, Ferrer I, Uziel G, Pujol A. Mitochondrial dysfunction in central nervous system white matter disorders. <span><span class="ref-journal">Glia. </span>2014;<span class="ref-vol">62</span>:1878–94.</span> [<a href="/pubmed/24865954" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24865954</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mt-overview.REF.murphy.2008.2832">Murphy JL, Blakely EL, Schaefer AM, He L, Wyrick P, Haller RG, Taylor RW, Turnbull DM, Taivassalo T. Resistance training in patients with single, large-scale deletions of mitochondrial DNA. <span><span class="ref-journal">Brain. </span>2008;<span class="ref-vol">131</span>:2832–40.</span> [<a href="/pubmed/18984605" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18984605</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mt-overview.REF.munnich.2001.4">Munnich A, Rustin P. Clinical spectrum and diagnosis of mitochondrial disorders. <span><span class="ref-journal">Am J Med Genet. </span>2001;<span class="ref-vol">106</span>:4–17.</span> [<a href="/pubmed/11579420" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11579420</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mt-overview.REF.nelson.1995.400">Nelson I, Hanna MG, Alsanjari N, Scaravilli F, Morgan-Hughes JA, Harding AE. A new mitochondrial DNA mutation associated with progressive dementia and chorea: a clinical, pathological, and molecular genetic study. <span><span class="ref-journal">Ann Neurol. </span>1995;<span class="ref-vol">37</span>:400–3.</span> [<a href="/pubmed/7695240" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7695240</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mt-overview.REF.nesbitt.2013.936">Nesbitt V, Pitceathly RD, Turnbull DM, Taylor RW, Sweeney MG, Mudanohwo EE, Rahman S, Hanna MG, McFarland R. The UK MRC Mitochondrial Disease Patient Cohort Study: clinical phenotypes associated with the m.3243A&#x0003e;G mutation--implications for diagnosis and management. <span><span class="ref-journal">J Neurol Neurosurg Psychiatry. </span>2013;<span class="ref-vol">84</span>:936–8.</span> [<a href="/pubmed/23355809" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23355809</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mt-overview.REF.poulton.2000.460">Poulton J, Turnbull DM. 74th ENMC International workshop: mitochondrial diseases 19-20 November 1999, Naarden, the Netherlands. <span><span class="ref-journal">Neuromuscul Disord. </span>2000;<span class="ref-vol">10</span>:460–2.</span> [<a href="/pubmed/10899455" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10899455</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mt-overview.REF.r_tig.1997.215">R&#x000f6;tig A, de Lonlay P, Chretien D, Foury F, Koenig M, Sidi D, Munnich A, Rustin P. Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia. <span><span class="ref-journal">Nat Genet. </span>1997;<span class="ref-vol">17</span>:215–7.</span> [<a href="/pubmed/9326946" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9326946</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mt-overview.REF.scaglia.2005.1675">Scaglia F, Wong LJ, Vladutiu GD, Hunter JV. Predominant cerebellar volume loss as a neuroradiologic feature of pediatric respiratory chain defects. <span><span class="ref-journal">AJNR Am J Neuroradiol. </span>2005;<span class="ref-vol">26</span>:1675–80.</span> [<a href="/pubmed/16091512" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16091512</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mt-overview.REF.scarpelli.2013.520">Scarpelli M, Ricciardi GK, Beltramello A, Zocca I, Calabria F, Russignan A, Zappini F, Cotelli MS, Padovani A, Tomelleri G, Filosto M, Tonin P. The role of brain MRI in mitochondrial neurogastrointestinal encephalomyopathy. <span><span class="ref-journal">Neuroradiol J. </span>2013;<span class="ref-vol">26</span>:520–30.</span> [<a href="/pmc/articles/PMC4202835/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4202835</span></a>] [<a href="/pubmed/24199812" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24199812</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mt-overview.REF.schon.1997.131">Schon EA, Bonilla E, DiMauro S. Mitochondrial DNA mutations and pathogenesis. <span><span class="ref-journal">J Bioenerg Biomembr. </span>1997;<span class="ref-vol">29</span>:131–49.</span> [<a href="/pubmed/9239539" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9239539</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mt-overview.REF.skladal.2003.1905">Skladal D, Halliday J, Thorburn DR. Minimum birth prevalence of mitochondrial respiratory chain disorders in children. <span><span class="ref-journal">Brain. </span>2003;<span class="ref-vol">126</span>:1905–12.</span> [<a href="/pubmed/12805096" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12805096</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mt-overview.REF.taivassalo.2006.3391">Taivassalo T, Gardner JL, Taylor RW, Schaefer AM, Newman J, Barron MJ, Haller RG, Turnbull DM. Endurance training and detraining in mitochondrial myopathies due to single large-scale mtDNA deletions. <span><span class="ref-journal">Brain. </span>2006;<span class="ref-vol">129</span>:3391–401.</span> [<a href="/pubmed/17085458" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17085458</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mt-overview.REF.taivassalo.2001.133">Taivassalo T, Shoubridge EA, Chen J, Kennaway NG, DiMauro S, Arnold DL, Haller RG. Aerobic conditioning in patients with mitochondrial myopathies: physiological, biochemical, and genetic effects. <span><span class="ref-journal">Ann Neurol. </span>2001;<span class="ref-vol">50</span>:133–41.</span> [<a href="/pubmed/11506394" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11506394</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mt-overview.REF.tay.2004.950">Tay SK, Shanske S, Kaplan P, DiMauro S. Association of mutations in SCO2, a cytochrome c oxidase assembly gene, with early fetal lethality. <span><span class="ref-journal">Arch Neurol. </span>2004;<span class="ref-vol">61</span>:950–2.</span> [<a href="/pubmed/15210538" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15210538</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mt-overview.REF.taylor.2014.68">Taylor RW, Pyle A, Griffin H, Blakely EL, Duff J, He L, Smertenko T, Alston CL, Neeve VC, Best A, Yarham JW, Kirschner J, Schara U, Talim B, Topaloglu H, Baric I, Holinski-Feder E, Abicht A, Czermin B, Kleinle S, Morris AA, Vassallo G, Gorman GS, Ramesh V, Turnbull DM, Santibanez-Koref M, McFarland R, Horvath R, Chinnery PF. Use of whole-exome sequencing to determine the genetic basis of multiple mitochondrial respiratory chain complex deficiencies. <span><span class="ref-journal">JAMA. </span>2014;<span class="ref-vol">312</span>:68–77.</span> [<a href="/pmc/articles/PMC6558267/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6558267</span></a>] [<a href="/pubmed/25058219" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25058219</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mt-overview.REF.thorburn.2001.102">Thorburn DR, Dahl HH. Mitochondrial disorders: genetics, counseling, prenatal diagnosis and reproductive options. <span><span class="ref-journal">Am J Med Genet. </span>2001;<span class="ref-vol">106</span>:102–14.</span> [<a href="/pubmed/11579429" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11579429</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mt-overview.REF.tiranti.2009.200">Tiranti V, Viscomi C, Hildebrandt T, Di Meo I, Mineri R, Tiveron C, Levitt MD, Prelle A, Fagiolari G, Rimoldi M, Zeviani M. Loss of ETHE1, a mitochondrial dioxygenase, causes fatal sulfide toxicity in ethylmalonic encephalopathy. <span><span class="ref-journal">Nat Med. </span>2009;<span class="ref-vol">15</span>:200–5.</span> [<a href="/pubmed/19136963" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19136963</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mt-overview.REF.uziel.1997.16">Uziel G, Moroni I, Lamantea E, Fratta GM, Ciceri E, Carrara F, Zeviani M. Mitochondrial disease associated with the T8993G mutation of the mitochondrial ATPase 6 gene: a clinical, biochemical, and molecular study in six families. <span><span class="ref-journal">J Neurol Neurosurg Psychiatry. </span>1997;<span class="ref-vol">63</span>:16–22.</span> [<a href="/pmc/articles/PMC2169628/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2169628</span></a>] [<a href="/pubmed/9221962" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9221962</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mt-overview.REF.van_den_ouweland.1992.368">van den Ouweland JM, Lemkes HH, Ruitenbeek W, Sandkuijl LA, de Vijlder MF, Struyvenberg PA, van de Kamp JJ, Maassen JA. Mutation in mitochondrial tRNA(Leu)(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness. <span><span class="ref-journal">Nat Genet. </span>1992;<span class="ref-vol">1</span>:368–71.</span> [<a href="/pubmed/1284550" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1284550</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mt-overview.REF.wallace.1999.1482">Wallace DC. Mitochondrial diseases in man and mouse. <span><span class="ref-journal">Science. </span>1999;<span class="ref-vol">283</span>:1482–8.</span> [<a href="/pubmed/10066162" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10066162</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mt-overview.REF.white.1999a.474">White SL, Collins VR, Wolfe R, Cleary MA, Shanske S, DiMauro S, Dahl HH, Thorburn DR. Genetic counseling and prenatal diagnosis for the mitochondrial DNA mutations at nucleotide 8993. <span><span class="ref-journal">Am J Hum Genet. </span>1999a;<span class="ref-vol">65</span>:474–82.</span> [<a href="/pmc/articles/PMC1377946/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1377946</span></a>] [<a href="/pubmed/10417290" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10417290</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mt-overview.REF.white.1999b.899">White SL, Shanske S, McGill JJ, Mountain H, Geraghty MT, DiMauro S, Dahl HH, Thorburn DR. Mitochondrial DNA mutations at nucleotide 8993 show a lack of tissue- or age-related variation. <span><span class="ref-journal">J Inherit Metab Dis. </span>1999b;<span class="ref-vol">22</span>:899–914.</span> [<a href="/pubmed/10604142" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10604142</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mt-overview.REF.wu.2016.1034">Wu L, Peng J, Ma Y, He F, Deng X, Wang G, Lifen Y, Yin F. Leukodystrophy associated with mitochondrial complex I deficiency due to a novel mutation in the NDUFAF1 gene. <span><span class="ref-journal">Mitochondrial DNA A DNA MappSeq Anal. </span>2016;<span class="ref-vol">27</span>:1034–7.</span> [<a href="/pubmed/24963768" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24963768</span></a>]</div></li></ul></div></div><div id="mt-overview.Chapter_Notes"><h2 id="_mt-overview_Chapter_Notes_">Chapter Notes</h2><div id="mt-overview.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>14 August 2014 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>16 September 2010 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>18 December 2003 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>8 June 2000 (tk, pb) Overview posted live</div></li><li class="half_rhythm"><div>20 April 2000 (eh) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1224</span><span class="label">PMID: <a href="/pubmed/20301403" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301403</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/mtdna-md-ov/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/mt-mpan/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1224&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1224/?report=reader">PubReader</a></li><li><a href="/books/NBK1224/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1224" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1224" style="display:none" title="Cite this Page"><div class="bk_tt">Chinnery PF. Mitochondrial Disorders Overview. 2000 Jun 8 [Updated 2014 Aug 14]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1224/pdf/Bookshelf_NBK1224.pdf">PDF version of this page</a> (513K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#mt-overview.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#mt-overview.Definition" ref="log$=inpage&amp;link_id=inpage">Definition</a></li><li><a href="#mt-overview.Causes" ref="log$=inpage&amp;link_id=inpage">Causes</a></li><li><a href="#mt-overview.Establishing_the_Diagnosis_o" ref="log$=inpage&amp;link_id=inpage">Establishing the Diagnosis of a Mitochondrial Disorder</a></li><li><a href="#mt-overview.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#mt-overview.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#mt-overview.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#mt-overview.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#mt-overview.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=1355[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">COX15</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=4513[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">MT-CO2</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=4535[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">MT-ND1</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=4579[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">MT-TY</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=4577[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">MT-TV</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=1352[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">COX10</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=4511[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">MT-TC</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=6389[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">SDHA</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=4574[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">MT-TS1</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=4564[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">MT-TH</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=4519[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">MT-CYB</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=4512[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">MT-CO1</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=4575[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">MT-TS2</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=4572[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">MT-TQ</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=4565[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">MT-TI</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=4567[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">MT-TL1</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=4578[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">MT-TW</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=4514[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">MT-CO3</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=4558[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">MT-TF</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=4571[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">MT-TP</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=617[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">BCS1L</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=4536[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">MT-ND2</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=4553[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">MT-TA</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=4566[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">MT-TK</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=4569[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">MT-TM</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=4573[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">MT-TR</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=4568[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">MT-TL2</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=4508[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">MT-ATP6</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=112812[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">FDX2</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=4541[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">MT-ND6</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=6834[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">SURF1</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=4539[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">MT-ND4L</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=4576[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">MT-TT</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=4540[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">MT-ND5</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=4538[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">MT-ND4</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=4555[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">MT-TD</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1460540" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1460540" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301411" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> MELAS</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> MELAS<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">El-Hattab AW, Almannai M, Scaglia F. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301352" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Mitochondrial DNA-Associated Leigh Syndrome and NARP</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Mitochondrial DNA-Associated Leigh Syndrome and NARP<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Thorburn DR, Rahman J, Rahman S. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301353" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Leber Hereditary Optic Neuropathy</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Leber Hereditary Optic Neuropathy<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Yu-Wai-Man P, Chinnery PF. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301693" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> MERRF</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> MERRF<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">DiMauro S, Hirano M. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301382" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Mitochondrial DNA Deletion Syndromes</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Mitochondrial DNA Deletion Syndromes<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Goldstein A, Falk MJ. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301403" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301403" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e040ef3dd21425a25743f1f">Mitochondrial Disorders Overview - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Mitochondrial Disorders Overview - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:37:55-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal103&amp;ncbi_phid=CE8A08C7E03FDDC10000000006AD025F&amp;ncbi_session=CE8A08C7E040EF31_1709SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1224%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1224&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1224/&amp;ncbi_pagename=Mitochondrial Disorders Overview - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8A08C7E040EF31_1709SID /projects/books/PBooks@5.22 portal103 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>